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MEETING ABSTRACTS
Abstracts from the 20th International 
Symposium on Signal Transduction at the 
Blood-Brain Barriers
Kraków, Poland. 13-15 September 2017
© The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
A0 
The 20th International Symposium on Signal Transduction at the 
Blood–Brain Barriers
Andrzej Małecki1, Janina Skipor‑Lahuta2, Michal Toborek 1,3
1The Jerzy Kukuczka Academy of Physical Education, Katowice, Poland, 
2The Institute of Animal Physiology and Food Research, Polish Academy 
of Sciences, Olsztyn, Poland, 3University of Miami, Miami, FL, USA
The 20th International Symposium on Signal Transduction at the 
Blood–Brain Barriers took place from September 13–15, 2017 in Kraków, 
Poland. The Organizers were the Jerzy Kukuczka Academy of Physical 
Education in Katowice, the Institute of Animal Reproduction and Food 
Research, Polish Academy of Sciences in Olsztyn as well as the Branches 
of the Polish Academy of Sciences in Olsztyn & Białystok and in Kraków. 
The Symposium Organizing Committee included Daniela Kasprowska-
Liśkiewicz, Marta Nowacka-Chmielewska, Joanna Śrubarczyk, Andrzej 
Małecki (all from the Jerzy Kukuczka Academy of Physical Education 
in Katowice), Mariusz Piskuła (the President of the Olsztyn & Białystok 
Branch of the Polish Academy of Sciences), Janina Skipor-Lahuta, Alek-
sandra Szczepkowska (both from the Institute of Animal Physiology 
and Food Research of the Polish Academy of Sciences in Olsztyn), Irena 
Nalepa and Władysław Lasoń (both from Institute of Pharmacology of 
the Polish Academy of Sciences in Krakow). The Committee was chaired 
by Michal Toborek (the Jerzy Kukuczka Academy of Physical Education 
in Katowice and University of Miami, USA).
The Symposium program covered all areas of blood–brain barriers 
research with the focus on the latest developments in neurodegen-
erative diseases, membrane receptors and transporters, transcytosis 
regulators, epigenetic and transcriptional regulators, metabolic and 
nutrition regulation, in vivo and in vitro brain barriers models as well 
as the role of junctional complexes. In addition, signaling pathways 
implicated in the development of neurological diseases and brain 
tumors were addressed. The symposium aimed to encourage interac-
tions between basic science researchers and clinicians working in aca-
demia, universities, and industry.
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Fig. 1 Participants of the 20th International Symposium on Signal Transduction at the Blood–Brain Barriers as divided by countries in which their 
research is performed
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The program included three keynote presentations by Mikio Furuse 
(National Institute for Physiological Sciences, Japan) “Molecular basis 
of paracellular diffusion barrier”, Michal Schwartz (Weizmann Insti-
tute of Science, Israel) “Harnessing systemic immunity to combat 
Alzheimer’s disease”, and Britta Engelhardt (University of Bern, Swit-
zerland) “Brain Barriers: The movers and shapers in immune privilege 
of the CNS”. In addition, there were 8 sessions: Session 1: Junctional 
complexes of the brain barriers—beyond barrier regulation, Session 
2: Pathology of the brain barriers—various aspects, Session 3: Blood–
brain barrier and HIV reservoirs in the CNS—formation and eradica-
tion, Session 4: Pathology of the brain barriers—experimental aspects, 
Session 5: Pathology of the brain barriers—clinical aspects, Session 6: 
Interactions between the brain barriers and stem cells in the CNS, Ses-
sion 7: Brain barriers and the metabolic axis, and Session 8: Behavioral 
modulations of the blood–brain barrier: diet and exercise. Session 3 
was sponsored by the National Institutes of Health/National Institute 
of Mental Health; NIH/NIMH, USA, and Session 8 was sponsored by the 
Institute of Animal Reproduction and Food Research, Polish Academy 
of Sciences, and the Jerzy Kukuczka Academy of Physical Education, 
Poland. In addition, there was a Poster Session.
There were 140 participants from 23 countries (Figure 1). The Interna-
tional Brain Barriers Society (IBBS) sponsored the Best Poster Awards. 
The winners were: Mette Mathiesen Janiurek (Copenhagen University, 
First Place), Chih-Chieh Tsao (University of Zurich, Second Place), and 
Alexa Fries (Charité-Universitätsmedizin Berlin, Third Place). 
A1 
The puzzle of the paracellular pathway
N. Joan Abbott
Institute of Pharmaceutical Science, King’s College London, London, UK
Correspondence: N. Joan Abbott (joan.abbott@kcl.ac.uk)  
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The paracellular pathway (PP) of the BBB is the extracellular cleft 
between adjacent endothelial cells that form the barrier. The permea-
bility of the pathway is regulated especially by the tight junctions (TJ), 
supported by the adherens junctions (AJ). Many experimental studies 
including measuring solute flux across the BBB and transendothelial 
electrical resistance (TEER) indicate that the PP in brain capillaries is 
considerably more restricted than that of the peripheral vasculature 
such as skeletal and heart muscle, largely attributed to tighter TJs. 
Much recent work has focused on the molecular analysis of tight junc-
tion proteins, especially claudins. One main driver for this research is 
the need to improve drug delivery to the brain, with modulation of TJs 
to open up the PP a current focus.
Some topics relevant to behaviour of the PP have received less atten-
tion, such as the relation of the TJ to AJ and indeed to gap junctions 
between endothelial cells, the influence of the glycocalyx on the 
luminal surface of the endothelium and of associated cells on the 
basal surface (pericytes, astrocytes). Now is a good time to bring in 
again the ‘bigger picture’, incorporating some excellent experimental 
work from the past and insights from recent work, both experimen-
tal and modelling, including relating physiological function of the 
BBB and PP to details revealed by both molecular analysis and high 
resolution imaging including electron microscopy. The talk will cover 
cell and molecular biology in the context of the physiological func-
tions of the BBB in helping regulate the fluid microenvironment of 
the brain.
A2 
Inhibiting occludin Ser490 phosphorylation prevents 
intracerebral hemorrhage in stroke
David A. Antonetti 1, Enming Joe  Su2, Daniel A.  Lawrence2
1Department of Ophthalmology and Molecular and Integrative 
Physiology, The University of Michigan, Ann Arbor, MI, USA, 2Department 
of Internal Medicine and Cardiology, The University of Michigan, Ann 
Arbor, MI, USA
Correspondence: David A. Antonetti (dantonet@med.umich.edu)  
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Stroke remains a leading cause of morbidity and mortality with lim-
ited therapeutic options. The current standard of care for patients 
with moderate to severe ischemic stroke is thrombolytic therapy with 
tissue plasminogen activator (tPA), which can significantly improve 
neurological outcome if given within 4 hours of stroke onset. How-
ever, later treatment with tPA increases the risk of intracerebral hemor-
rhage. Understanding and preventing tPA induced hemorrhage may 
lead to improved and extended use of thrombolytic therapy. Previ-
ous studies reveal that tPA may increase brain vascular permeability 
through cleavage and activation of PDGF-CC. In addition, research has 
demonstrated that growth factors in the VEGF and PDGF family lead 
to increased Ser490 phosphorylation of the tight junction protein 
occludin in a protein kinase C (PKC)dependent manner and mutating 
Ser490 to Ala (S490A) can prevent VEGF induced vascular endothelial 
permeability. In the current study we hypothesized that Ser490 phos-
phorylation was required for tPA-induced hemorrhagic transformation 
in the middle cerebral artery occlusion (MCAO) model of stroke. Pho-
tothrombotic MCAO was induced in C57BL/6J mice, tPA gene deletion 
mice or mice carrying the occludin S490A mutant at the Rosa26 locus 
under the CAG promoter followed by a floxed stop sequence and 
crossed with PDGFiCre for tamoxifen-induced vascular specific expres-
sion. MCAO induced a dramatic increase in OccS490 phosphorylation 
in the penumbra as determined by immunofluorescence microscopy 
using a P-S490 specific antibody. MCAO in tPA deleted animals, which 
previously were shown to prevent the increase in vascular permeabil-
ity, also blocked occludin phosphorylation. Pretreatment of animals 
with a PKCbeta inhibitor prevented the MCAO induced permeability 
to dextran and prevented occludin phosphorylation. Further, expres-
sion of S490A occludin also prevented MCAO-induced vascular perme-
ability. Importantly S490A mice also completely blocked hemorrhagic 
transformation in MCAO with late tPA thrombolysis (5h after MCAO). 
PKCbeta inhibitors also completely blocked hemorrhagic transforma-
tion induced by late tPA thrombolysis after MCAO when the kinase 
inhibitor was given 1h after MCAO. These results provide compelling 
evidence that PKCbeta phosphorylation of occludin Ser490 contrib-
utes to vascular permeability after MCAO and hemorrhagic transfor-
mation with late tPA treatment. The studies suggest that inhibition 
of PKCbeta may provide an opportunity to extend tPA treatment to a 
broader group of stroke patients.
Grant Support: This study was supported by NIH EY012021 and sup-
port from RPB to DAA and NIH HL-055374 and NS-079639 to DAL
A3 
Effects of methyl‑beta‑cyclodextrin on blood–brain barrier 
permeability in acute hypertension induced by angiotensin‑II
Müge Atış1, Uğur  Akcan2, Canan Uğur Yılmaz3, Nurcan  Orhan4, Poyraz 
Düzgün5, Umut Deniz  Ceylan5, Nadir Arıcan6, Serçin Karahüseyinoğlu7, 
Gizem Nur Şahin1, Bülent Ahıshalı8, Mehmet  Kaya9
1Koc University, School of Medicine, Department of Cellular and Molecular 
Medicine, Istanbul, Turkey, 2Koc University, School of Medicine, 
Department of Neuroscience, Istanbul, Turkey, 3Istanbul University, 
Aziz Sancar Experimental Medicine Research Institute, Department 
of Laboratory Animals Science, Istanbul, Turkey, 4Istanbul University, 
Aziz Sancar Experimental Medicine Research Institute, Department 
of Neuroscience, Istanbul, Turkey, 5Koc University, School of Medicine, 
Istanbul, Turkey, 6Istanbul University, Istanbul Faculty of Medicine, 
Department of Forensic Science, Istanbul, Turkey, 7Koc University, School 
of Medicine, Department of Histology and Embryology, Istanbul, Turkey, 
8Istanbul University, Istanbul Faculty of Medicine, Department of Histology 
and Embryology, Istanbul, Turkey, 9Koc University, School of Medicine, 
Department of Physiology, Istanbul, Turkey
Correspondence: Mehmet Kaya (mkaya942@gmail.com)  
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The loss of blood–brain barrier (BBB) integrity primarily occurs in 
cerebral venules and veins during acute hypertensive conditions. 
Methyl-beta-cyclodextrin (MBCD) causes cholesterol depletion from 
the cell plasma membrane and leads to caveolar transport disrup-
tion. The present study was intended to examine the effects of MBCD 
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on the functional and structural properties of barrier type of brain 
microvessels in angiotensin (ANG) II–induced acute hypertension 
in rats. The experimental groups were designed as control, MBCD, 
ANG-II, and MBCD+ANG-II. BBB permeability was evaluated by deter-
mining extravasation of Evans blue (EB) and horseradish peroxidase 
(HRP) tracers. At five minutes after MBCD administration (5 mg/kg), 
acute hypertension was induced by ANG-II (60 µg/kg), and arterial 
blood pressure measurements were taken. ANG-II caused a significant 
increase in arterial blood pressure when compared with baseline val-
ues (p<0.01). The content of EB dye in the left and right cerebral cor-
tex and left hippocampus regions of animals significantly increased 
in ANG-II, MBCD, and MBCD+ANG-II groups when compared with 
controls (p<0.05). Ultrastructurally, frequent vesicles which did not 
contain HRP reaction products were observed in endothelial cells of 
venules and veins in the cerebral cortex and hippocampus regions of 
brains of animals in ANG-II, and MBCD+ANG-II groups. HRP reaction 
products were mainly observed in astrocytes and neurons of the brain 
regions. Our results revealed that MBCD did not provide overall pro-
tective effects on the BBB integrity in acute hypertensive conditions 
and even led to BBB disruption in intact animals.
Keywords: Acute hypertension, Blood–brain barrier, Methyl-beta-
cyclodextrin, Electron microscopy, Horseradish peroxidase, Evans blue
A4 
The role of endothelial antigen‑presentation in the migration 
of  CD8+Tcells across the blood–brain barrier in neuroinflammation
Sidar Aydin, Armelle Klopstein, Britta Engelhardt
Theodor Kocher Institute, University of Bern, Bern, Switzerland
Correspondence: Sidar Aydin (sidar.aydin@tki.unibe.ch)  
Fluids and Barriers of the CNS 2017, 14(Supp 2):A4
Multiple sclerosis (MS) is the most common inflammatory disease of 
the central nervous system (CNS) with unknown etiology to this date. 
Accumulating evidence points to a critical role of  CD8+ T cells in MS 
pathogenesis. Immune cell recruitment into the CNS is controlled by 
the blood–brain barrier (BBB). The molecular mechanisms mediating 
the multi-step migration of  CD8+ T cells across the BBB are incom-
pletely understood. It has been suggested that endothelial antigen 
(Ag)-presentation contributes to  CD8+ T-cell entry into the CNS. This 
prompted us to study if BBB endothelium can present Ag and if this 
process may contribute to  CD8+ T-cell trafficking across the BBB. Using 
primary mouse brain microvascular endothelial cells (pMBMECs) as in 
vitro model for the BBB we found up-regulation of MHC-class I expres-
sion but also of the co-inhibitory molecule PD-L1 after 24 hours of 
stimulation with TNF-α/IFN by immunofluorescence (IF) staining. To 
investigate whether stimulated pMBMECs can induce Ag-dependent 
T-cell proliferation, we co-cultured CSFE-labeled T-cell receptor trans-
genic OT-I  CD8+ T-cells recognizing the ovalbumin peptide SIINFEKL 
in the context of  H2Kb, with Ag-pulsed stimulated pMBMECs. Irrespec-
tive of the presence or absence of SIINFEKL, pMBMECs induced the 
proliferation of the naïve OT-I T cells as visualized by CFSE-dilution 
employing flow cytometry. Also, β2-microglobulin deficient (β2M -/-) 
pMBMECs induced OT-I cell proliferation suggesting that pMBMECs 
can induce proliferation of naïve OT-I cells in an antigen and MHC class 
I independent fashion. At the same time we observed that OT-I cells 
killed WT but not β2M-/-pMBMECs in the presence of the SIINFEKL pep-
tide, suggesting that full activation of OT-I effector functions needs 
engagement of OT-I cells with endothelial MHC class I presenting their 
cognate antigen. By employing in  vitro live cell imaging, we finally 
asked if endothelial Ag-presentation contributes to the multi-step 
extravasation of activated OT-I cells across the BBB under physiological 
flow. Presence or absence of SIINFEKL peptide on MHC-class I express-
ing pMBMECs did not affect OT-I cell arrest on pMBMECs under physi-
ological flow. However, in presence of SIINFEKLOT-I cell crawling was 
significantly reduced. This was accompanied by rapid OT-I cell medi-
ated killing of pMBMECs under flow. Thus brain endothelial Ag-pres-
entation triggers rapid  CD8+ T-cell mediated killing of BBB endothelial 
cells under physiological flow in vitro. Taken together out data suggest 
that Ag-presentation by brain endothelial cells may lead to  CD8+ T-cell 
mediated focal BBB breakdown, which is recognized as a major hall-
mark of MS pathogenesis.
A5 
Inhibition of Furin arrests brain endothelial cell migration 
and prevents TGFβ‑mediated permeability changes at the blood–
brain barrier
Julia  Baumann1,2, Chih‑Chieh  Tsao1,2, Sheng‑Fu  Huang1,2 and Omolara 
 Ogunshola1,2
1Institute of Veterinary Physiology, Vetsuisse Faculty, University of Zurich, 
Zurich, Switzerland, 2Zurich Center for Integrative Human Physiology, 
University of Zurich, Zurich, Switzerland
Correspondence: Julia Baumann (julia.baumann2@uzh.ch)  
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A stable well-functioning blood–brain barrier (BBB), formed by special-
ized endothelial cells (EC), is crucial to maintain and control cerebral 
homeostasis. Indeed increased barrier permeability is a common fea-
ture of numerous CNS insults and diseases. Our group has identified 
transforming growth factor β (TGFβ) to be involved in vessel perme-
ability changes in vivo. TGFβ is known to affect cell migration but also 
exerts apoptotic effects giving various potential mechanisms to dis-
rupt the barrier. TGFβ induces the expression of Furin, a ubiquitously 
expressed proprotein convertase that stimulates extracellular matrix 
degradation and cell movement. This study aimed to investigate the 
potential roles of TGFβ and Furin in hypoxic barrier disruption.
In a Lucifer yellow-based transwell setup exogenous TGFβ (0.25μM) 
increased permeability of primary endothelial cells, but had no effect 
on cell viability. Subsequent in vitro experiments were performed on 
rat brain microvascular ECs (RBE4) exposed to normoxia and hypoxia 
(1%  O2) for 6h. EC migration tended to increase already within 6h of 
hypoxia and exposure to TGFβ significantly potentiated this effect. 
Hypoxic exposure in presence of exogenous TGFβ increased both 
Furin protein levels and activity. Blockade of the TGFβ-receptor I 
(ALK5) with 10μM SB431542 reduced Furin protein levels indicating 
that its activation relies on the TGFβ signaling pathway. Importantly, 
pharmacological inhibition of Furin with Naphthofluorescein (20μM) 
not only prevented hypoxic EC migration but also abrogated the 
TGFβ-induced potentiation. Taken together our data suggests a crucial 
role for Furin in mediating hypoxic and TGFβ-induced BBB permeabil-
ity changes after insult. Such insights present novel potential targets 
for future therapy during injury and disease.
Grant Support: This work is supported by an SNF Grant 31003A_170129 
to O.O
A6 
Assessment of viral inflammation in the blood–brain barrier 
model in vitro
Elizaveta B.  Boytsova1,2, Andrey V.  Morgun2,3, Elena D.  Khilazheva1,2, 
Elena A.  Pozhilenkova1,2, Yana V.  Gorina1,2, Galina P.  Martynova4, Alla B. 
 Salmina1,2.
1 Dept. of Biochemistry, Medical, Pharmaceutical and Toxicological 
Chemistry, Krasnoyarsk State Medical University named after Prof. 
V.F. Voino‑Yasenetsky of the Ministry of Public Health, Krasnoyarsk, 
Russian Federation, 2 Research Institute of Molecular Medicine 
and Pathobiochemistry, Krasnoyarsk State Medical University named 
after Prof. V.F. Voino‑Yasenetsky of the Ministry of Public Health, 
Krasnoyarsk, Russian Federation, 3 Dept. of Pediatrics, Krasnoyarsk 
State Medical University named after Prof. V.F. Voino‑Yasenetsky of the 
Ministry of Public Health, Krasnoyarsk, Russian Federation, 4 Dept. 
of Pediatric Infectious Diseases, Krasnoyarsk State Medical University 
named after Prof. V.F. Voino‑Yasenetsky of the Ministry of Public Health, 
Krasnoyarsk, Russian Federation
Correspondence: Elizaveta B. Boytsova (elizaveta.boicova@mail.ru)  
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Neuroinflammation caused by infectious agents (bacteria, viruses, fungi) 
is an important component in the pathogenesis of numerous brain 
diseases. The key mechanisms of brain tissue alterations and increased 
permeability of the blood–brain barrier (BBB) at the loci of neuroinflam-
mation remain insufficiently studied, thereby limiting the approaches to 
establish novel effective protocols for the pharmacotherapy of central 
nervous system inflammatory diseases. The problems of modelling neu-
roinflammation in vitro remain to be solved as well.
The aim of the study was to create an aseptic model of viral neuroin-
flammation in vitro using poly (I:C) as a viral inflammatory inducer and 
cerebrospinal fluid (CSF) derived from patients with viral meningitis to 
study some mechanisms of BBB impairment in neuroinflammation.
We used methods of molecular profiling to evaluate the expression of 
molecules in the BBB model in vitro cells involved in the response of 
cells to the effects of poly (I:C) and cerebrospinal fluid from patients 
with viral meningitis: tight gap junction proteins (ZO1, CLDN5), matrix 
metalloproteinase-9 (MMP9), components of inflammasome NLRP3. 
We applied cell biology approaches for the isolation of rat progeni-
tor cells (neuronal precursors and astroglia), rat cerebral endothelial 
cells, establishment of mixed cultures (neurons, astrocytes, endothe-
lial cells) and BBB model in vitro. Transendothelial electrical resistance 
(TEER) of endothelial cell layer was registered to evaluate BBB perme-
ability in vitro. The study design included 6 groups. Group 1 was the 
BBB model in vitro exposed to poly (I:C). Group 2 was the BBB model in 
vitro exposed to cerebrospinal fluid obtained from patients with viral 
meningitis. Group 3 was a culture of cerebral endothelial cells with 
the addition of poly (I:C). Group 4 was a culture of endothelial cells 
exposed to CSF derived from patients with viral meningitis. Group 5 
was a non-treated rat BBB model in vitro. Group 6 was a non-treated 
culture of rat cerebral endothelial cells.
We found that in groups 1, 2, 3, and 4, the number of cells express-
ing CLDN5, MMP9 and NLRP3 was higher than in the control group 
(p<0.05). The maximum changes have been registered in cerebral 
endothelial cells cultured with viral CSF: the number of cells express-
ing CLDN5, MMP9, NLRP3 was significantly increased comparing 
with group 3 (poly (I:C)) -p<0.05. However, in rat BBB model in  vitro, 
expression of NLRP3 and MMP9 in neurons and astrocytes was higher 
(p<0.05) in the group with poly (I:C) than in the group 2 (CSF-treated). 
Interestingly, the number of endothelial cells expressing ZO1 did not 
differ from the control group. Nevertheless, the TEER in all the experi-
mental groups was significantly decreased in comparison with the 
control group (p <0.05).
Application of the BBB model in  vitro with the addition of poly (I:C) 
and/or cerebrospinal fluid obtained from patients with viral meningitis 
is useful for modelling neuroinflammation and studying the perme-
ability of BBB.
The study is supported by the grant #16-44-243073 given by the RFBR 
and the Krasnoyarsk scientific foundation.
A7 
Regulation of embryonic cerebrospinal fluid composition: 
evolutionary implications for brain development and function
David Bueno, Jordi Garcia‑Fernàndez
Biomedical Genetics, Evolution and Development Section, Department 
of Genetics, Microbiology and Statistics, Faculty of Biology, University 
of Barcelona, Barcelona, Catalonia (Spain)
Correspondence: David Bueno (dbueno@ub.edu)  
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The evolution of the centralised nervous system is believed to have 
been a critical step in the adaptive radiation of vertebrates, especially 
in terms of brain structure and function. The architecture of the ver-
tebrate brain primordium reveals the existence of connected inter-
nal cavities, the cephalic vesicles, which during foetal development 
become the ventricular system of the brain seen in adults. These 
cavities are filled with a complex, protein-rich fluid called cerebrospi-
nal fluid (CSF). In this respect, chordates invariably possess a dorsal 
neural tube, while ambulacrarians exhibit an open plate-like nervous 
system, which is in close contact with the environment. It has been 
proposed that the evolutionary occurrence of a hollow nerve chord 
was fundamental to the origin of chordates, as the composition of the 
fluid in contact with the neurons no longer depended directly on the 
surrounding environment, but became much more strictly regulated 
by the activity and metabolism of the organism. Interestingly, this 
evolutionary process parallels developmental and regulatory aspects 
of some vertebrates. It has been demonstrated in higher vertebrates 
that embryonic CSF is key to delivering diffusible signals and nutrients 
to the developing brain, thereby contributing to the proliferation, dif-
ferentiation and survival of neural progenitor cells, and to the expan-
sion and patterning of the brain. Moreover, it has also been shown 
that the composition and homeostasis of CSF are tightly controlled 
from early stages of brain development, just after the closure of the 
anterior neuropore, before the choroid plexus (the organ producing 
CSF in foetuses and adults) becomes physiologically functional. Thus, 
this developmental process, from the closure of the neuropores to 
the maturation of the choroids plexus, together with the evolution of 
brain cavities and CSF formation constitute a fertile example of what 
it is called evo-devo (for evolutionary development). It has important 
implications for brain development and function.
A8 
Regulatory impact of occludin on the formation of HIV reservoirs 
in neural progenitor cells and brain pericytes
Victor Castro, Marta Skowronska, Michal Toborek
Department of Biochemistry and Molecular Biology, University of Miami 
School of Medicine, Miami, FL, USA
Correspondence: Michal Toborek  
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HIV interactions with the cells of the blood–brain barrier (BBB) and 
the role of tight junction proteins in brain infection by HIV are poorly 
understood. HIV infection of pericytes results in biphasic changes 
in occludin levels, which are inversely correlated with the rate of 
infection. Specifically, depletion in occludin levels in the first 48 h of 
infection is strongly associated with an active HIV transcription and 
decreased expression and activation of the class-III histone deacety-
lase SIRT-1. Indeed, occludin has activity of a NADH oxidase that con-
trols the expression and activation of SIRT-1. Furthermore, the viral 
core promoter contains two binding sites for the nuclear factor-κB (NF-
κB), which plays a central role in the proviral activation pathway and 
stimulation of transcriptional elongation by the p65 subunit. The activ-
ity of NFκB is modulated by acetylation; thus, decreased deacylation 
due to lower SIRT-1 activity may drive stimulation of HIV transcription. 
Interestingly, decreased levels of occludin resulted in a substantial 
stimulation in HIV transcription rates but only limited increase in viral 
release, implying that far more virus is produced in pericytes than 
released into the medium. Similar results were obtained in neural pro-
genitor cells, suggesting that both cell types may potentially form viral 
reservoirs in the brain. Indeed, at later stages of infection, elevated lev-
els of occludin were associated with incorporation of HIV DNA into the 
host genome in both pericytes and neural progenitor cells. Our find-
ings show for the first time that occludin plays an important role in HIV 
infection by regulating the NFκB/SIRT-1 pathway and can influence 
the transition between active and latent HIV infection.
This work was supported by the National Institutes of Health (NIH), 
grants MH072567, MH098891, HL126559, and DA039576.
A9 
Modulation of blood–brain barrier integrity 
through anti‑inflammatory effect of combined exercise training 
and taurine supplementation in elderly
Matheus Uba  Chupel1, Luciele Guerra  Minuzzi1, Edith  Filaire2, Ana Maria 
 Teixeira1
1Research Center for Sport and Physical Activity, Faculty of Sport Science 
and Physical Education, University of Coimbra, Coimbra, Portugal, 2CIAMS, 
University of Orleans, Orleans, France
Correspondence: Matheus Uba Chupel (mtoborek@med.miami.edu)  
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Immunosenescence can lead to increased concentrations of pro-
inflammatory cytokines such as IL-1β and TNF-α, which could induce 
blood–brain barrier (BBB) permeability in elderly people [1, 2], leading 
to cognitive impairment [3]. Exercise and nutritional therapies are non-
pharmacological tools which emerged against immunosuppression-
related diseases [4, 5]. Exercise is pointed out to modulate immune 
function in elderly [6, 7], however, evidence regarding long-term exer-
cise and BBB integrity is still unknown in this population. Concerning 
nutrition, taurine supplementation has been investigated in humans 
due to its anti-inflammatory and antioxidant effects [8], nevertheless, 
little is known regarding its effects in BBB permeability, cognition and 
inflammation in elderly persons. The objective of this study was to ver-
ify the effects of exercise and supplementation with taurine on blood 
levels of peripheral markers of BBB permeability (S100β and neuronal 
specific enolase—NSE), and on IL-1β, IL-1ra, IL-17, myeloperoxidase 
(MPO), matrix-metalloprooteinase-9 (MMP-9) and cognition of elderly 
women.
48 institutionalized elderly women (83.58±6,9 years) were enrolled in 
the study. Subjects were divided into four groups: combined exercise 
training (CET: n=13), taurine supplementation (TAU: n=12), exercise 
with taurine (CET+TAU: n=11) and control group (CG: n=12). CET was 
done 2 times per week involving strength, aerobic and flexibility com-
ponents. Taurine supplementation was given (1,5g/day). Interventions 
lasted 14 weeks, and subjects were evaluated before (T0) and after 
(T1) this period. Blood was collected in both moments to determine 
the biological markers concentration and the Mini-Mental State Exam-
ination (MMSE) was applied to examine global cognition.
There was a significant time*treatment effect on S100β, NSE and 
MMSE after intervention (p<0.05). S100β slightly decreased in all inter-
vention groups, and increased in controls, where NSE levels also rose. 
Regression analyses including cytokines change showed that only 
group membership significantly determined change in S100β, while 
there was also a trend for change in IL-1 to be independently associ-
ated with variations in S100b (p=.054). Subsequently, univariate anal-
yses were carried out and indicated that MPO and MMP-9 decreased 
in TAU group (p<0.05) and no changes were observed for the other 
groups. Group membership was an independent predictor of MMSE 
changes with variation in monocytes as an independent predictor. 
Meanwhile, correlation between changes showed an association 
between IL-17 and S100β changes.
Exercise and taurine supplementation reduced the peripheral marker 
of BBB permeability by an immunomodulatory mechanism, however, 
only the exercising elderly improved cognition.
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Alzheimer’s disease (AD) is severe progressive neurodegenerative 
disorder characterized by abnormal accumulation of the β-amyloid 
(Aβ) peptides in senile plaques as well as in the walls of intracerebral 
microvessels forming the blood–brain barrier (BBB). This barrier repre-
sents a tight and highly regulated barrier between the blood and the 
brain cells and is a key player in AD. To date, there are no effective drug 
therapies for AD, and the development of new alternative therapeu-
tic approach is therefore necessary, such as nutritional strategies; one 
possible approach is represented by the ketogenic diet (KD), already 
used as a non-drug treatment for epilepsy.
KD is a diet high in fat, adequate-proteins and low carbohydrates pro-
ducing ketone bodies (KBs) which represent an alternative energy 
source to glucose for brain cells and, unlike glucose transport, their 
entry across the BBB is not affected in AD. Animal studies suggest that 
KBs have a beneficial effect on AD by their neurotrophic effect, but also 
by decreasing the amount of Aβ peptides accumulation. However, why 
and how KBs impact brain microvessels and consequently cerebral Aβ 
accumulation is not well elucidated.
With this consideration in mind, it seems essential to focus on the 
BBB’s receptors/transporters and enzymes involved in Aβ peptide 
transport and metabolism, to better understand the influence of a KD 
on the onset and the evolution of this disease.
For 12 weeks, Wild type 129Sv (WT) and transgenic TgCRND8 (AD) 
mice were maintained on KD or Control Diet (CD) diets (N=6 per diet). 
Body weight was measured, and microvessel fractions were isolated 
from total brain. qPCR analyses were performed to study expression of 
transporters, receptors and enzymes implicated in KBs, glucose and in 
Aβ peptide transport and synthesis at the BBB level.
Our results showed a weight gain in AD mice after three months KD 
and a modulation in the expression of some Aβ transporters and 
enzymes at brain microvessels level. In particular in response to KD, 
the expression levels of these genes return to similar values to those 
of WT mice.
This work suggests that it may be possible to modulate Aβ transport 
and synthesis at the BBB level by controlling dietary intakes. However, 
a period of less than three months needs to be tested to evaluate the 
impact of this diet for a shorter period in order to be easily transfered 
to clinical trials.
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Pericytes, mural cells of small blood vessels, are highly abundant in 
cerebral capillaries, which form the blood–brain barrier (BBB). There is 
increasing evidence that pericytes are crucial for both the development 
and maintenance of the BBB. In many CNS pathologies, like stroke and 
Alzheimer’s disease pericyte dysfunction contributes to BBB damage 
and neuronal loss. Co-culture models are unique tools to study cellu-
lar interactions and reveal endothelial-pericyte crosstalk. We have pio-
neered static and dynamic blood–brain barrier co-culture models using 
not only two cell types, brain endothelial cells and glial cells, but also a 
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third one, brain microvascular pericytes [1, 2]. These complex models 
revealed that brain pericytes are able to strengthen the barrier proper-
ties of brain endothelial cells, which is reflected by increased transen-
dothelial resistance and decreased permeability for marker molecules. 
Co-culture with pericytes increases the expression and junctional local-
ization of claudin-5, occludin and ZO-1. The expression of important 
BBB transporters, like BCRP (ABCG2), EAAT-1 and-2, and enzymes such 
as γ-glutamyl-transpeptidases, and nitric oxide synthase 1 and 2 are 
elevated by pericytes. Extracellular matrix components of pericytes also 
contribute to BBB properties and enhanced expression of tight junction 
proteins. The complex effects of pericytes were observed in BBB culture 
models from different species, including rat, mouse, porcine, monkey 
and human. Co-culture with pericytes increases key barrier properties, 
thus contributes to better BBB function of the in vitro models.
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Hereditary Diffuse Leukoencephalopathy with Spheroids (HDLS) is a 
rare neurodegenerative leukoencephalopathy presenting clinically 
as cognitive dysfunction, memory deficit and motor impairment. 
Neuropathological examination reveals axonal swellings (spheroids), 
neurofilament and Ab positivity within the white matter of affected 
individuals. The causative gene for this monogenic dominant disorder 
encodes the colony stimulating factor 1 receptor (CSF1R); previously 
known to be involved in the differentiation, maturation and regulation 
of immune cells in the myeloid lineage and brain microglia, this recep-
tor tyrosine kinase and binds two ligands CSF1 and interleukin-34 the 
latter of which is enriched in nervous tissue. Classically associated with 
macrophage function, the CSF1R gene has been revealed to have a 
critical role in microglial viability as well as the response of the cen-
tral nervous system (CNS) to injury and stress revealing a new regu-
lator in central nervous system (CNS) homeostasis. Recently we have 
identified two familial cohorts of HDLS with perivascular pathologies 
including amyloid beta accumulation like identical to that observed in 
Alzheimer’s disease, astroglial and microglial activation, and an accom-
panying increase in BBB permeability. Functional analyses of HDLS-
variant CSF1R in vitro revealed conserved but reduced translation and 
membrane localisation, indicating that CSF1R haploinsufficiency alone 
may not be required for HDLS pathogenesis. We have identified aber-
rant post-translational processing and functionality of mutant-CSF1R 
and propose these altered characteristics and subsequent BBB dys-
function, rather than loss of function, may drive HDLS pathology.
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To maintain the brain with energy substrates and essential nutrients, 
endothelial cells express specific transporters of the SLC-type that are 
located in their luminal and/or abluminal membranes and transfer 
substrates down prevailing concentration gradients. (Brain endothelial 
cells also express ATP-dependent efflux transporters that work against 
concentration gradients, prevent entry of xenobiotics and drugs, 
and export physiological end products.) Of the more than 450 SLC-
type transporters in the human genome, many are present in brain 
endothelial cells. Because of the critical role that endothelial cells and 
the neurovascular unit play in maintaining brain homeostasis, it is pre-
dicted that any disruption in transporter activity will lead to disruption 
of brain function and a neuropathological outcome. This, indeed, is the 
case and more than eight of the major blood–brain transporters, when 
dysfunctional in humans due to mutation, cause a serious neurologi-
cal consequence ranging from microcephaly to intellectual disability. 
As the number of defective blood–brain transporters expands so does 
the challenge to find cures or treatments that ameliorate the associ-
ated conditions.
A recent addition to this list is the monocarboxylic acid transporter-
1(MCT1, SLC16A1) and is documented by two reports of human sub-
jects with MCT1 deficiency. A cohort of 96 pediatric patients with 
unexplained severe ketoacidosis was examined by a Dutch group [1] 
and subjects with both homozygous and hemizygous MCT1 inactivat-
ing mutations were identified. This study was corroborated by a report 
of MCT1 heterozygous Australian children who experienced similar 
symptoms [2]. Mutations in MCT1 may also lead to lactic acid accumu-
lation in muscle and inhibition of contraction.
To gain new insights, MCT1 function and regulation were investigated 
in cells that are devoid of MCT1 or are functionally blocked by specific 
inhibitors. Using Seahorse technology, we have examined glycolysis 
and respiration in human Hap1 cells in which MCT1 is knocked out. 
Compared to wild type Hap1 cells, the respiratory rate for Hap1  MCT1(-) 
cells is ~50% and the glycolytic rate is ~90% indicating that mitochon-
drial function is greatly compromised compared to glycolysis when 
MCT1 is not expressed. In addition, the growth (proliferation) rate of 
the Hap1 KO cells is about 50% of the wild type. Furthermore, no dif-
ference in mitochondrial content as determined by quantifying COX-
IV expression was observed. This strongly suggests that MCT1 plays a 
dual role in plasma membrane transport and also mitochondria func-
tion. Not only will our results provide new insights into MCT1 function, 
but the findings may be transferrable to studies of other brain barrier 
transporters, their functions, expression regulation and the design of 
potential therapeutic strategies.
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Previously, many efforts were done to date to create a cell culture 
model closely mimicking the properties of the human blood–brain 
barrier (BBB) in vivo. By using primary cells or immortalized cell lines, 
only unsatisfying results comprising major deficits, could be produced 
so far. A promising alternative represent human induced pluripotent 
stem cells (hiPSC). The advantage of using hiPSC is, next to eliminating 
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species-specific differences, the infinite and ethically inoffensive 
cell source that can be used as donor material. In addition, it is well-
known that cell-cell communication between single players of the 
neurovascular unit, established through physical interaction or diffu-
sion of certain molecules predominantly transported by extracellular 
vesicles, is necessary to simulate in  vivo-like barrier properties. Here, 
we present a highly suitable, easy to culture in  vitro model combin-
ing hiPSC-derived BBB endothelial cells with astrocytes, pericytes and 
NSCs, showing in vivo like characteristics including a transendothelial 
electrical resistance (TEER) up to 2,500 Ω  cm2 and distinct upregula-
tion of typical BBB genes i.e. tight junction proteins and BBB-specific 
transporters [1].
One prospective focus to obtain further knowledge about cell-cell 
communication and target cell modification would pose inclusion of 
non-destructive analysis techniques like multi electrode arrays and 
impedance measurements that can be implemented to optimize and 
simplify the model evaluation in mid and high throughput pre-clini-
cal screening applications. Therefore, an interdisciplinary consortium 
of industrial and scientific research facilities recently joined within a 
newly BMBF-funded project named HiPSTAR (Human iPS Cell-Based 
BBB Technology in Alzheimer Research), combining individual exper-
tise like organ on a chip systems, high-throughput screens of certain 
drug libraries, patient-specific BBB modeling or in silico prediction of 
the BBB. This consortium might reveal valuable new tools not only 
for Alzheimer research but also other related neurodegenerative and 
brain inflammatory disorders with increasing prevalence.
1. Appelt-Menzel A, Cubukova A, Günther K, Edenhofer F, Piontek 
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Due to the highly specialized nature of the brain barriers tissues, as 
well as their development and maintenance process, transcriptome 
profiling is a vital tool to better understand processes in the blood–
brain Barrier (BBB). In particular, RNA-seq techniques have provided 
the opportunity of more thorough studies in many fields of life sci-
ences. Interestingly, the number of studies taking advantage of this 
technique to study the brain barriers is still very low when compared 
to the total number of publications concerning the brain barriers. 
However, we expect that (i) the number of studies using RNA-seq will 
increase dramatically and (ii) these methodologies will help to bring 
the knowledge of the BBB to a new level.
We are currently developing “BBBHub”—a web based data hub plat-
form (i) to collect existing and new data (ii) to integrate and organize 
the omics-data (mainly RNA-seq) (iii) to implement data-mining tools 
and (iv) to provide the data to both researchers and general public. For 
the implementation of the BBBHub, we will use the frame work “open-
BIS”, an open source platform for managing scientific information, as 
its backbone. Furthermore, we are developing an easy-to-use front-
end system to allow all researchers to use it independently of their 
computational expertise.
In the context of the BBBHub, we are setting up standardized data 
analysis workflows to allow for a more efficient comparison between 
datasets and are currently working on quality control determination 
features. These features will be very helpful to understand the utility 
and limitations of each dataset.
Grant support: EU H2020-MSCA-ITN-2015 675619 BtRAIN
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Despite decades of research, processes leading to the intravascular 
inflammatory response accompanying subarachnoid hemorrhage 
(SAH) remain elusive. The herein presented study focusses on investi-
gating the extent and the progression of blood–brain barrier (BBB) dis-
ruption in a SAH mouse model and the influence of proinflammatory 
interleukin (IL) 6 on BBB integrity and composition post SAH.
SAH was induced in wildtype (WT) and IL6 knock out (IL6KO) mice by 
filament perforation. BBB breakdown was evaluated by the extravasa-
tion of the fluorescent tracer Evans Blue on day 4 in SAH- and SHAM-
operated mice (controls). Endothelial expression of cell contact 
molecules and pro-inflammatory mediators IL6, tumor-necrosis fac-
tor α (TNFα), IL1β and matrix metalloproteinase 9 (MMP9) was exam-
ined in freshly isolated cerebral capillaries employing real-time qPCR. 
The distribution of collagen IV as well as apoptotic pericytes (stained 
by desmin) were analyzed by immunofluorescence and TUNEL-Kit, 
respectively.
The most remarkable BBB leakage (approximately 4-fold of the con-
trol) and IL6 gene overexpression (2.7 ± 0.5-fold) was observed on day 
4 due to SAH in WT mice. The pronounced expression of IL6 accom-
panying BBB breakdown makes this molecule interesting for further 
investigation. BBB leakage was significantly reduced in IL6-deficient 
mice. Our analysis revealed SAH-operated WT mice to show a signifi-
cant decrease in the transcript level of occludin (0.5 ± 0.3-fold) but 
not claudin-5 (1.3 ± 0.3-fold) compared to IL6KO mice. Furthermore, 
we detected an upregulation of proinflammatory TNFα and IL1β in 
WT mice while this overexpression was attenuated in IL6KO mice (3.3 
± 1.2-fold and 2.8 ± 1.2-fold, respectively). The extracellular matrix 
degrading protease MMP9 was significantly elevated in SAH WT com-
pared to IL6KO mice (2.2 ± 0.4-fold). Additionally, the MMP9 substrate 
collagen IV was significantly lowered in SAH WT mice (0.7 ± 0.2-fold) 
whereas both, SAH as well as SHAM IL6KOs showed a relatively low 
expression of this molecule. Finally, we noted a higher number of 
apoptotic pericytes in SAH-operated WT mice in comparison to IL6KOs 
after SAH (3.1 ± 1.0-fold).
The dynamics observed in IL6 deficient mice nominate this molecule 
as an important target in the reduction of BBB breakdown post SAH. 
Its proinflammatory influence on cerebrovascular leakage and its reg-
ulation of barrier tightening molecules implicate the critical involve-
ment of this cytokine in second brain injury.
Grant support: This study was financially supported by Deutsche 
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Epithelial and endothelial tight junctions (TJs) restrict free diffu-
sion of solutes through the paracellular pathway to separate two 
fluid compartments. The claudin family, which comprises more 
than 20 subtypes, are major structural integral membrane proteins 
directly involved the barrier function of TJs. A multitude of stud-
ies have revealed that part of claudin subtypes function as pores for 
electrolytes rather than strict barriers in TJs, and the combinations of 
expressed claudin subtypes determine the permeability properties of 
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individual epithelia depending on their physiological requirements. 
Consistent with this concept, the loss of function not only of barrier 
type claudins but also of pore type claudins cause various disorders 
in claudin knockout mice and human hereditary diseases. In addition 
to TJs between adjacent cells, the paracellular pathway contains the 
extracellular space at tricellular contacts, where the vertices of three 
cells meet. These regions should also be plugged to maintain the bar-
rier function of the cellular sheet. This task is performed by specialized 
structures of TJs at tricellular contacts, designated tricellular TJs (tTJs), 
which appear to obliterate the extracellular space there. Two types 
of integral membrane proteins, angulin family proteins (angulin-1/
LSR, angulin-2/ILDR1 and angulin-3/ILDR2) and tricellulin are known 
as molecular constituents of tTJs. Angulins recruit tricellulin to tricel-
lular contacts and both proteins are required for full barrier function 
of the cellular sheet. Although the impact of tTJs in epithelial functions 
appears less than that of TJs, angulin-2/ILDR1 knockout mice have 
been reported to exhibit several disorders, suggesting crucial roles of 
tTJ. To clarify the whole picture of the paracellular diffusion barrier, tTJs 
need to be studied further at a molecular level in addition to claudin-
based TJs.
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Protocadherins (Pcdhs) belong to a large family of cadherin-related 
molecules and are organized in three large clusters, alpha, beta and 
gamma Pcdhs. They are highly expressed in the central nervous sys-
tem (CNS). Pcdhs play a role in cell adhesion, cellular interactions and 
development of the CNS. Expression of Pcdhs has been well charac-
terized in neurons, astrocytes, pericytes and in epithelial cells of the 
choroid plexus. Recently, we analyzed the expression of multiple 
Pcdhs in endothelial cells from several vascular beds. We analyzed 
human (hCMEC/D3) and mouse brain microvascular endothelial cell 
lines (BMEC) (cEND and cerebEND) as well as primary mouse BMEC. 
In addition, we analyzed mouse myocardial microvascular endothelial 
cell line (MyEND) and human umbilical vein endothelial cells (HUVEC). 
Using qPCR, Western blot and immunostaining we showed a strong 
mRNA expression of Pcdhs in all endothelial cells tested. We studied 
in more detail the expression of Pcdh-gamma. All members of Pcdh-
gamma family can be detected with an antibody against the con-
served C-terminal domain. Immunostaining of Pcdh-gamma showed 
diffused cytoplasmic localization in mouse BMEC. Interestingly, Pcdh-
gamma protein level was higher in confluent endothelial cell cultures 
in comparison to non-confluent cultures. In order to study the role 
of Pcdh-gamma in BMEC in detail, we established a knockout of one 
representative Pcdh-gamma family member, PcdhgC3, using CRISPR/
Cas9 system. Deletion of PcdhgC3 led to changes in the permeability 
and transendothelial electrical resistance (TEER). Moreover, expression 
of several tight junction proteins as well as transporters and cellular 
receptors was changed in knockout cells. The knockout cells migrated 
faster that the wild type cells and showed differences in adhesion to 
extracellular matrix components. Our results thus suggest a central 
role of Pcdhs in the barrier-stabilizing pathways at the blood–brain 
barrier. However, more studies are needed to clarify the role of Pcdhs 
in brain endothelial cells and other cell types of the neurovascular unit.
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Endothelial Wnt/β-catenin signaling is necessary for developmental 
angiogenesis of the central nervous system (CNS) and differentiation 
of the blood–brain barrier (BBB), and it appears to be active at low lev-
els also in the adult to maintain BBB characteristics. In the adult brain, 
pericytes and astrocytes are the closest cellular neighbours of the bar-
rier endothelium in the neuro-vascular unit (NVU). Although both cell 
types participate in BBB maintenance and integrity, their contribution 
to Wnt growth factor release and Wnt/β-catenin signaling is poorly 
understood. To characterise AC-derived Wnts in BBB maintenance, 
we made use of GFAP-Cre:Evilox/lox mice  (AC∆Evi), in which ACs cannot 
release Wnts, because the Evi/wntless gene is missing, which is crucial 
for Wnt growth factor secretion.
AC∆Evi mice are viable and show no obvious gross phenotype. However, 
detailed analysis revealed a mild brain oedema and increased tracer 
permeability in vivo, indicating a partially dysfunctional BBB that did not 
affect mouse viability. Interestingly, significant oedema was observed in 
the cortex and subcortical regions but not in the cerebellum of  AC∆Evi 
mice, suggesting regional differences in Wnt secretion from ACs.
Analysis of vascular structure showed no significant alterations of 
vessel density and branching however, the structure of aquaporin-4 
positive End-feet on microvessels was altered in  AC∆Evi mice. Electron 
microscopy confirmed a selective swelling of astrocyte end-feet, likely 
accounting for the observed BBB defect. Moreover, microvessels of 
 AC∆Evi mice showed increased vesicle incidence.
Isolated brain microvascular fragments revealed downregulated barrier-
related and Wnt target genes in  AC∆Evi mice. Additionally,  AC∆Evi mice 
displayed structural alterations of endothelial cell-to-cell junctions.
In summary,  AC∆Evi mice reveal that astrocyte-derived Wnt growth fac-
tors are required to maintain the adult BBB function and cellular integ-
rity of the NVU in an astrocyte cell-autonomous fashion.
A20 
Blood–brain barrier is protected against cytokine‑induced 
damage by α‑melanocyte stimulating hormone: a culture study
András  Harazin1, Alexandra  Bocsik1, Judit Váradi2, Ferenc  Fenyvesi2, Vilmos 
 Tubak3, Miklós Vecsernyés2, Mária A.  Deli1
1Institute of Biophysics, Biological Research Centre, Hungarian Academy 
of Sciences, Szeged, Hungary, 2Department of Pharmaceutical 
Technology, Faculty of Pharmacy, University of Debrecen, Debrecen, 
Hungary, 3Creative Laboratory Ltd, Szeged, Hungary
Correspondence: András Harazin (harazin.andras@brc.mta.hu)  
Fluids and Barriers of the CNS 2017, 14(Supp 2):A20
The anti-inflammatory and protective effect of the α-melanocyte 
stimulating hormone (αMSH) was demonstrated in animal models 
of diseases, such as ischemia-reperfusion or inflammations. In these 
pathological situations inflammatory mechanisms are triggered and 
maintained by proinflammatory cytokines, such as tumor necrosis 
factor-α (TNFα) and interleukin-1β (IL-1β) which also damage the func-
tion of biological barriers. Recently we have demonstrated, that αMSH 
could attenuate the inflammatory effects of TNFα and IL-1β on Caco-2 
intestinal epithelial cells [1]. The effect of this neuropeptide on blood–
brain barrier culture model has not been investigated yet. Our aim was 
to examine the effect of αMSH on cytokine-treated brain endothelial 
cells using a co-culture model.
Primary rat brain endothelial cells were co-cultured with rat brain 
pericytes and glial cells. We examined the expression of melanocor-
tin-1 receptor (MC1R) by immunhistochemistry and RT-PCR. TNFα and 
IL-1β (10 ng/ml) were used to induce cell damage. Cell viability was 
measured by impedance (RTCA-SP, ACEA Biosciences) and MTT assay. 
Function of the barrier was tested by electrical resistance (TEER) and 
permeability measurements. Morphological changes of the junc-
tional proteins and translocation of the inflammatory NF-κB transcrip-
tion factor p65 subunit were visualized by immunhistochemistry and 
confocal microscopy. Reactive oxygen species production in brain 
endothelial cells was measured by DCFDA reagent.
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We verified the presence of the MC1R mRNA and protein in brain 
endothelial cells. The neuropeptide αMSH (1 and 10 pM) showed no 
effect on rat brain endothelial cells alone, but increased the cell via-
bility, decreased brain endothelial permeability, inhibited reactive 
oxygen species production, the morphological changes of junctional 
proteins and the nuclear translocation of NF-κB in cytokine induced 
damage. We demonstrated for the first time the protective effect of 
αMSH on cultured brain endothelial cells indicating the potential 
application of αMSH to protect the blood–brain barrier
Grant support: GINOP-2.2.1-15-2016-00007; GINOP-2.3.2-15-2016-00060
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The amino acid L-glutamate is an important excitatory neurotransmit-
ter in the mammalian brain and a key player in a number of pathologies. 
Excessive interstitial fluid concentrations of L-glutamate cause excitotox-
icity, and several mechanisms in the CNS act to keep L-glutamate levels 
low. The role of astrocytes in this respect is well characterized, however 
the role of the brain endothelial cells is still unclear. Excitatory amino 
acid transporters (EAAT’s of the SLC1 family) have been shown to be 
expressed in the abluminal membrane of brain endothelial cells from 
humans, rats, calves and pigs. A number of studies also indicate that the 
brain endothelium can mediate a vectorial transport of L-glutamate in the 
brain-to-blood direction. We evaluated the luminal and abluminal uptake 
and transendothelial transport of radiolabelled L-glutamate in electrically 
tight monolayers of bovine brain endothelial cells cultured either as non-
contact or contact co-cultures with rat astrocytes. Both luminal and ablu-
minal uptake followed apparent Michaelis-Menten kinetics. The abluminal 
uptake appeared to be dominated by EAAT-1, whereas luminal uptake 
was mediated via a carrier mechanism, which could not readily be identi-
fied on the molecular level. The metabolism of L-glutamate and transport 
of metabolites was investigated using [U-13C] L-glutamate, and it was 
demonstrated that intact L-glutamate, as well as metabolites were trans-
ported in the brain-to blood direction. Overall, our studies indicated that 
the concerted action of abluminal and luminal L-glutamate transporters 
mediate transendothelial transport of L-glutamate, but also that overall 
clearance of abluminal L-glutamate is highly dependent on metabolism.
Grant support: Birger Brodin and Hans Christian Helms would like to 
acknowledge the support from the Lundbeck Foundation Research 
Initiative on Brain Barriers and Drug Delivery (RIBBDD).
A22 
Characteristics of the blood–brain barrier in a novel model 
of vascular neurodegeneration
Zsófia  Hoyk1#, Melinda E. Tóth2#, Nikolett Lénárt2, Brigitta  Dukay2, Ágnes 
 Kittel4, Judit Vígh1, Szilvia  Veszelka1, Fruzsina  Walter1, Ágnes  Zvara3, László 
Puskás3, Mária A.  Deli1#, Miklós Sántha1#
1Institute of Biophysics, Biological Research Centre, Hungarian Academy 
of Sciences, Szeged, Hungary, 2Institute of Biochemistry, Biological 
Research Centre, Hungarian Academy of Sciences, Szeged, Hungary, 
3Institute of Genetics, Biological Research Centre, Hungarian Academy 
of Sciences, Szeged, Hungary, 4Institute of Experimental Medicine, 
Hungarian Academy of Sciences, Budapest, Hungary
Correspondence: Zsófia Hoyk (zsofi@brc.hu) and Mária A. Deli (deli.
maria@brc.mta.hu)  
#Zsófia Hoyk, Melinda E. Tóth, Mária A. Deli and  Miklós Sántha contrib‑
uted equally to this work
Fluids and Barriers of the CNS 2017, 14(Supp 2):A22
High triglyceride levels are known risk factors for cardio- and cerebro-
vascular diseases. A growing number of evidence suggests that dys-
lipidemia is associated with neurodegenerative diseases, too. However, 
data are lacking on the cellular and molecular characteristics of the 
neurovascular unit in hypertriglyceridemia. In the present study neuro-
vascular changes—brain vessel permeability, gene expression changes 
and morphology of the cells of the neurovascular unit in the hippocam-
pus and frontal cortex—were examined in ApoB-100 transgenic mice, 
a model of human atherosclerosis. Increased extravasation of the small 
molecular marker fluorescein was observed in the hippocampus of 
transgenic mice, but not in the frontal cortex. No change was seen for 
albumin permeability between the groups or brain regions. The most 
striking change in gene expression was a drop in the homeobox gene 
Meox2 and the docosahexaenoic acid transporter Mfsd2a in the trans-
genic animals. By immunohistochemistry no difference was observed 
in the staining pattern of the tight junction proteins claudin-5 and 
occludin in brain microvessels and of microglia cells stained for marker 
Iba-1comparing the transgenic mice with their wild-type littermates. 
Astroglia cells in the frontal cortex, in contrast, showed marked altera-
tions. The GFAP immunoreactivity showed two types of staining pattern: 
it was detected in astroglial cell bodies and processes and in structures 
closely associated with brain capillaries but not linked to glial cells in 
wild-type animals, while in ApoB-100 transgenic mice the predominant 
GFAP immunostaining revealed a cellular pattern. Quantitative analysis 
of the area fractions and average size of GFAP and Iba-1 immunoreac-
tive structures revealed no difference between wild-type and transgenic 
mice. Vimentin immunoreactivity was typically observed along brain 
capillaries in the frontal cortex of wild-type animals. Electron microscop-
icy analysis of brain capillaries showed an increase in the ratio of discon-
tinuous tight junctions and edematous astrocytes in both the frontal 
cortex and hippocampus in ApoB-100 transgenic mice compared with 
wild-type animals. We conclude that the increased blood–brain barrier 
permeability, changes in genes regulating brain vessel integrity and 
tightness, and morphological changes in astroglia cells closely associ-
ated with brain capillaries might be linked in ApoB-100 transgenic mice.
Grant support: OTKA-NN111006, GINOP-2.3.2-15-2016-00060, 
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Glutathione (GSH) is a thiol compound present in high concentrations 
in cells of all organs’ it has many physiological functions including drug 
detoxification and defense against cell stress. Notably, in aging human 
brain and many neurological disorders and diseases it has been shown 
that GSH is below normal levels suggesting GSH is essential to support 
brain function. In the brain, astrocytes (ACs) are the major GSH produc-
ers and the cellular link between neurons and the blood–brain barrier 
(BBB). ACs secrete GSH to support neuronal survival but the contribu-
tions of GSH to BBB integrity are still unknown. The BBB is formed by 
endothelial cells (EC) that strictly control exchange between blood and 
brain compartment using tight junctions, maintaining brain homeosta-
sis. Our recent metabolomics data showed that GSH levels are higher in 
AC than EC during hypoxia/ischemia stimulating us to investigate GSH 
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crosstalk between AC and EC under stress. Our results show that exoge-
nous GSH improves EC tight junction localization and maintains EC mor-
phology during 48h of normoxia and hypoxia/ischemia. Furthermore, 
exogenous GSH prevented hypoxia/ischemia-induced EC barrier impair-
ment suggesting it benefits barrier stability. Interestingly, ACs rapidly 
secrete GSH during 16h of hypoxia and ischemia. In correlation, mRNA 
levels of the GSH transporters (MRP2 and MRP4) significantly increase in 
AC between 6h and 24h of hypoxia/ischemia. Moreover, the γ-glutamyl 
transferase mRNA, an extracellular GSH stabilizer, was upregulated after 
6h hypoxia/ischemia. These evidences indicate that ACs increase the 
secretion and stability of GSH during hypoxia/ischemia. We are currently 
tracking isotope labeled endogenous GSH movement in our AC-EC co-
culture system to confirm GSH shuttling from AC to endothelial cells. 
Such knowledge will provide potential candidates to develop novel 
strategies to reduce BBB impairment and brain injury.
Grant support: Swiss National Science Foundation grant 
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The Rett syndrome (RTT) is a pervasive developmental disorder, pri-
marily affecting girls with a prevalence of 1 in every 10,000 live births. 
It represents the second most common cause of intellectual disability 
in females. Children with RTT develop normally until 6–12 months of 
life. However, they subsequently lose learned skills like language and 
purposeful hand use, and develop irregular respirations in the wake 
period, gait abnormalities and seizures. RTT is known to be caused in 
95% of the cases by sporadic de novo loss-of-function mutations in 
the MECP2 gene. In recent years the focus of research expanded from 
neurons (which express MeCP2 to the highest content) to other CNS 
cells such as astrocytes and confirmed their mechanistic relevance for 
the disease. Despite the importance of the blood–brain barrier (BBB) 
for drug delivery of Rett-therapeutics and although it is known that 
the BBB functionality is changed during several neurodegenerative 
diseases, no data exist about the BBB and possible functional altera-
tions during RTT until now. Therefore, we studied the presence and 
functional relevance of MeCP2 at the BBB by comparing wild-type to 
MeCP2 knock-out mice. According to our results, MeCP2 is present in 
mouse brain endothelial cells shown in brain sections, isolated capil-
laries and isolated cells as well as in human cells of the neurovascu-
lar unit. After evaluation of tight junction and transporter molecule 
expression in vivo, significant differences could be found indicating 
changes of BBB functionality during RTT, which could be confirmed 
in vitro. Recombinant TAT-MeCP2 is currently under development as a 
therapeutic protein. Comprehensive uptake and functional in vitro as 
well as in vivo evaluation studies about the potential of TAT-MeCP2 as a 
drug were accomplished. In addition, an in vitro BBB model was estab-
lished to evaluate the BBB permeability of different TAT-MeCP2 prepa-
rations in order to lead and optimize the production process.
In summary, our data indicate that the BBB is changed during RTT and 
this probably influences CNS accessibility for drugs. Moreover, RTT is a 
novel example for a neurodegenerative disease with altered BBB func-
tionality. However, it has still to be investigated if this altered BBB func-
tionality is causally linked to the disease progression.
Grant support: This work was supported by the Germans parents asso-
ciation for children with RETT syndrome (“Elternhilfe für Kinder mit 
RETT-Syndrom”).
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Circadian rhythms are intrinsic biological processes that occur in 24 
hour oscillations. These enable an organism to anticipate and prepare 
for regular environmental changes and are regulated by external cues 
such as light and temperature. Photoreceptor outer segment (POS) 
phagocytosis is one process that occurs daily upon light onset. The 
involvement of circadian rhythms in retinal function, however, is still 
not fully elucidated. Here, we wished to study the role of circadian 
clock components in the regulation of processes directly related to the 
replenishment of shed POS’.
Wild-type C57BL6/J mice (10-12 weeks) were sacrificed at 8AM, 2PM, 
8PM and 2AM (8AM and 8PM corresponding to 12 h lights on: 12 
h lights off cycle) for in vivo analyses. Retinal protein and mRNA was 
extracted and tight junction (TJ) and circadian clock components 
analysed by western blotting and qRT-PCR, respectively. For verifi-
cation that the response was circadian rather than diurnal, further 
cohorts of C57BL6/J mice were housed in either 24 h of darkness or 
dark-adapted for three weeks, in which the light cycle was reversed, 
and subsequently sacrificed and retinal protein and mRNA analysed as 
above. Serum shock experiments were found to re-establish circadian 
rhythms in in vitro primary human retinal microvascular endothelial 
cells.
We found that TJ component claudin-5 cycled in the retinal vascu-
lature throughout the day and the clock component BMAL1 was 
required for claudin-5 cycling. Claudin-5 transcript and protein levels 
cycled throughout the day in a circadian-dependent, rather than diur-
nal manner, with lower levels at 8PM compared to 8AM. These changes 
phenotypically led to more permeable retinal vessels in the evening 
compared to morning as observed by fundus fluorescein angiography 
(FFA) and dynamic contrast enhanced magnetic resonance imaging 
(DCE-MRI) analyses. The observed effects were similarly seen in other 
wild-type mouse strains. Circadian-regulated changes in retinal vascu-
lar permeability was not evident in  BMAL1FL/FL-Tie-2 mice, where the 
clock gene BMAL1 was lacking in endothelial cells. Mice exposed to a 
high fat diet in tandem with persistent suppression of claudin-5 devel-
oped rapid onset of a geographic atrophy (GA) like phenotype, which 
is the end stage of the condition dry age-related macular degenera-
tion (AMD).
We have discovered that the inner blood-retinal barrier is highly 
dynamic and plays a critical role in replenishing POS. Circadian regula-
tion of claudin-5 facilitates the exchange of material between blood 
and the neural retina. Therefore, regulating claudin-5 or circadian clock 
components may represent a novel therapeutic target for treating GA.
This work has been supported by: Science Foundation Ireland and 
Health Research Board
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Human serum albumin (HSA) nanoparticles, modified with apolipo-
protein E (ApoE) or a polysorbate-80 coating, cross the blood–brain 
barrier (BBB) in vivo after intra-jugular injection. The biodegradable 
and non-antigenic nanoparticles were produced at a size of 200nm 
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diameter using the desolvation method and their surface modified 
with ApoE or polysorbate-80.
Electron microscopy showed the brain intracellular localization of the 
modified nanoparticles 15 min after intra-jugular injection. Whereas 
unmodified HSA nanoparticles were not seen within the brain tissue. 
The BBB crossing ability of the modified nanoparticles is mediated by 
receptor-mediated endocytosis followed by transcystosis involving 
the LRP1 receptor as demonstrated in vitro. However, the rapid speed 
of nanoparticle movement within the brain tissue remains surprising. 
Confocal microscopy confirmed electron microscopic findings, under-
lining the rapid movement of the modified HSA nanoparticles through 
the brain tissue following brain BBB endothelial cell internalization. 
Furthermore, it allowed for the precise quantification of the number 
of nanoparticles per cell in the brain and calculation of injected dose 
subsequently found in the brain. Surface modified HSA nanoparticles 
were located over 4μm from the closest vessel 15 min after injection. 
With an average size of 200 nm the nanoparticles are far too big to 
travel freely through the highly tortuous extracellular space. Further-
more, the modified nanoparticles were never seen extracellularly 
within brain, except for the basal lamina. Astrocytic end-feet cover-
ing the brain endothelial cells are well positioned to mediate further 
transport through the brain tissue. Cytoplasmic flow rates of 2-16 mm/
hr would explain the rapid rate of intracellular movement observed. 
Furthermore, the modified HSA nanoparticles were highly concen-
trated in the astrocytic end-feet 5 min after injection, shown by confo-
cal microscopy, and localized in the distal astrocytic processes 15 min 
after injection, as shown by 3D reconstruction. Within 30 minutes the 
HSA nanoparticles are distributed within the cytoplasm of neurones. 
These observations lead to a re-evaluation of the role of astrocytes in 
the rapid movement of large structures within the brain.
Quantification of the polysorbate-80 coating revealed a monomo-
lecular surfactant coverage of the nanoparticles. Investigating the 
protein corona developed on the nanoparticle surface upon contact 
with serum, with and without polysorbate-80 coating, is crucial in 
elucidating the biological identity and handling of the nanoparticles 
in vivo. SDS-PAGE and LC-MS analysis of the protein corona revealed 
a highly complex corona composition of adsorbed serum proteins 
including the presence of multiple LDL(LRP)-receptor ligands. An in 
depth understanding of the intracellular transport mechanism utilized 
by ApoE and polysorbate-80 modified HSA nanoparticles bears great 
promise for the future design of CNS targeted drug delivery systems 
for large protein-based therapeutics.
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Modulation of endogenous signalling pathways that regulate the 
blood–brain barrier (BBB) permeability represents a potential strategy 
for increased drug delivery to the brain. Sphingosine-1-phosphate 
receptors (S1PRs) are surface membrane receptors located on both the 
lumenal and ablumenal side of endothelial cells. In a healthy organism, 
the majority of the S1PR agonist, i.e. sphingosine-1-phosphate (S1P), is 
transported in the blood by the molecular chaperone, apolipoprotein-
M (ApoM). Disruption of the ApoM-S1P signalling, i.e. by lack of ApoM 
expression, is associated with an impaired endothelial barrier in the 
lungs, but its significance for the BBB integrity is not fully understood.
Aim: To determine the importance of the S1P/S1PR signaling pathway 
for endothelial function and BBB permeability.
We used in vivo two-photon fluorescence microscopy in  ApoM-/- mice 
with impaired ApoM/S1P signalling and wild type littermates. To moni-
tor BBB permeability in a living brain, water-soluble fluorophores of 
varying sizes, i.e. 0.365kDa Sodium Fluorescein, 0.643kDa Alexa488 and 
10KDa FITC-dextran were injected intravenously. The accumulation of 
the fluorophores was measured in real time in the brain parenchyma at 
a depths ranging from 0 to 120 μm relative to the brain surface.
Loss of ApoM-mediated S1P transport leads to increased permeability 
towards blood-circulating fluorescent molecules. Compared to wild-
type littermates, the BBB in  ApoM-/- mice exhibited a 5-fold increase 
in the accumulation of small fluorophores (<0.65kDa, i.e. Sodium Fluo-
rescein and Alexa488) within 30 minutes post injection. This effect was 
not observed with larger molecules, i.e. 10kDa FITC-dextran. Moreover, 
pharmacological modulation of S1P/S1PR pathway with S1PR agonist 
SEW2871 leads to reversal of the phenotype and partially reinstated 
the BBB integrity.
The BBB integrity towards blood circulating molecules can be altered 
by a targeted modulation of the S1P/S1PR/ApoM signalling, implying 
that this pathway plays an important role in maintaining the integrity 
of the BBB. Alteration of the BBB by disrupting ApoM/S1P/S1PR sign-
aling may be a novel target for bidirectional modulation of the BBB 
integrity for increased trans-BBB drug delivery to CNS. These findings 
are of relevance for understanding the mechanisms of neurodegen-
eration in chronic diseases, as well as for rescuing the BBB function in 
acute brain disorders.
A28 
The functional and inflammatory response of brain endothelial 
cells to toll‑like receptor agonists
Rebecca H  Johnson1,2, Dan T  Kho1,2, Simon J O’Carroll1,3, Catherine E 
 Angel4, E. Scott  Graham1,2.
1Centre for Brain Research, University of Auckland, Auckland, New 
Zealand, 2 Department of Pharmacology and Clinical Pharmacology, 
University of Auckland, Auckland, New Zealand, 3 Department 
of Anatomy and Medical Imaging, University of Auckland, Auckland, 
New Zealand, School of Medical Sciences, Faculty of Medical and Health 
Sciences, University of Auckland, Auckland, New Zealand, 4 School 
of Biological Sciences, Faculty of Science, University of Auckland, 
Auckland, New Zealand
Correspondence: E. Scott Graham (s.graham@auckland.ac.nz)  
Fluids and Barriers of the CNS 2017, 14(Supp 2):A28
Toll-Like Receptors (TLRs) represent an important early warning 
mechanism for the immune system to detect infection or tissue dam-
age, however there has been limited research investigating how dif-
ferent TLR ligands function in human brain microvascular endothelial 
cells. The focus of this research was to determine the downstream 
neuro-inflammatory responses of various TLR ligands and their effect 
on endothelial barrier strength. A range of commercially available 
TLR ligands were tested for their pharmacological response profiles 
using xCELLigence Biosensor technology which revealed that the 
brain endothelial cells responded to the TLR3 ligand Poly(I:C), the TLR 
4 ligand LPS and the FDA approved TLR7 ligand Imiquimod, but not 
to any other TLR agonists. Using Cytometric Bead Array it was found 
that whilst Poly(I:C) and LPS induced a pronounced pro-inflammatory 
response, Imiquimod did not induce the secretion of any pro-inflam-
matory cytokines. ECIS technology was used to determine temporal 
changes in endothelial barrier strength, which revealed that both 
Poly(I:C) and LPS have a similar effect on barrier integrity as TNFα. In 
contrast, Imiquimod was able to induce a rapid and sustained increase 
in barrier strength. In addition to this, it was further observed that 
Imiquimod was able to abrogate the production of some but not all 
pro-inflammatory cytokines and chemokines secreted during inflam-
matory activation of the brain endothelial cells. PCR analysis revealed 
that the brain endothelial cells lacked TLR7, and further xCELLigence 
experiments revealed that the novel response to Imiquimod was not 
replicated with a panel of alternative TLR7 ligands. This finding indi-
cates that novel receptors exist for Imiquimod (polypharmacology), 
which do not mediate a pro-inflammatory signal but can attenuate 
various pro-inflammatory responses including TNα, TLR3 and TLR4 
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agonists. The challenge now is to identify these immunosuppressive 
receptors and assess their therapeutic potential.
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In this research we have investigated the temporal regulation of brain 
endothelial barrier function following exposure to a variety of inflam-
matory mediators elevated in the serum of MS patients. It is well 
known that Relapsing Remitting MS is a chronic inflammatory dis-
ease with evidence of autoimmune dysfunction, therefore our serum 
cytokine panel was biased towards Th1, Th17 and leukocyte recruit-
ment/activation mediators. In the MS sera, we detected elevated 
levels of (i) IL-1β, IL2, IL-4, IL6, IL-12, IL17, IFNs, (ii) the chemokines 
fractalkine, MCP-1, IP-10, RANTES, IP-10, MIP1α, and (iii) various growth 
factors including GCSF and GMCSF. Each of these were then applied 
to an immortalised human brain endothelial cell culture model sys-
tem with barrier function measured using ECIS technology. Of all 
of the cytokines assessed, IL-1β and TNFα had the greatest effect on 
barrier strength. We observed a small transient reduction in barrier 
strength (in the first 10-14 hours), which was followed by a sustained 
strengthening by both IL-1β and TNFα (50-500pg/mL). IFNγ mediated 
a similar change in barrier strength. These responses were concentra-
tion dependent with IL-1β being the most potent. In contrast, IFNα 
caused the immediate strengthening of the barrier, whereas both IL6 
and IL4 caused progressive weakening. Even though these cytokines 
influenced barrier function in different ways as demonstrated by the 
temporal power of ECIS technology, they each stimulated the brain 
endothelial cells causing increased secretion of various pro-inflamma-
tory cytokines and chemokines. Most of the other factors measured in 
the sera from the MS patients did not have any influence on the barrier 
function or viability of the brain endothelial cells used in this study. We 
conclude that human brain endothelial cells are sensitive to a range 
of pleiotropic cytokines that are elevated in the sera of patients with 
RRMS. It is quite plausible that some or a combination of these may 
influence the BBB integrity and contribute to the leakiness occurring 
in regions of the brain susceptible to the formation of lesions.
Research Support: Neurological Foundation of New Zealand, and the 
University of Auckland Faculty Research Development Fund.
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The presence of an intact, impermeable blood–brain barrier (BBB) dur-
ing the early (micrometastatic) stages of tumour cell colonisation signifi-
cantly limits early detection and effective treatment of brain metastasis. 
Systemic administration of tumour necrosis factor (TNF) in murine mod-
els transiently permeabilises the BBB selectively at sites of micrometas-
tasis in the brain. This phenomenon facilitates enhanced detection of 
metastatic colonies with contrast-enhanced MRI and improved delivery 
of therapeutically-relevant molecules to the tumour site [1].
The aim of this study was to determine why tumour-associ-
ated endothelium becomes susceptible to TNF-induced BBB 
permeabilisation.
Immortalized human brain microvascular endothelial cells (hCMEC/
D3) were exposed to the supernatants of human brain-seeking 
metastatic cancer cells (breast, MDAMB231Br; lung, SEBTA001; or 
melanoma, H1DL2), non-brain-targeting cancer cells (MDAMB231), 
cytokines (human TNF, huTNF; or a novel TNFR1-selective mutein, 
mutTNF) and TNFR1 siRNA. Expression of the endogenous receptors 
for TNF (TNFR1, TNFR2) was evaluated by qPCR and immunostaining. 
Alterations in paracellular permeability were measured using fluores-
cent dextrans.
The hCMEC/D3 monolayer showed significantly increased TNFR1 
expression when stimulated with either brain-trophic tumour cells 
or tumour-conditioned media (ca. 120-fold for breast, 280-fold for 
lung, 260-fold for melanoma, p<0.001). In contrast, hCMEC/D3 TNFR2 
expression was minimal on stimulation with breast or lung metastatic 
cells, and only modestly increased for melanoma cells (ca. 97-fold, 
p<0.001). No effect of non-brain targeting cancer cells on expression 
of either receptor was evident. Importantly, hCMEC/D3 treatment 
with cytokines, after stimulation of TNFR1 expression with tumour 
conditioned media from metastatic breast cancer cells, significantly 
increased permeability (ca. 15-fold for huTNF, 11-fold for mutTNF, 
p<0.001), whereas similar treatment on TNFR1-silenced, stimulated 
hCMECs did not exert any significant alterations in permeability.
Histological evaluation of tumours revealed that 55-80% (depending 
on tumour type) of vessels were TNFR1 positive up to a distance of 
0.001- 0.099mm from the tumour boundary and 15-30% of vessels at 
a distance of 0.1-1mm from the tumour . Less than 10% of vessels were 
TNFR2 positive in all models.
These data confirm the specific upregulation of TNFR1 on tumour-
activated endothelial cells both in vitro and in vivo within the tumour 
microenvironment. This study reveals that brain-seeking metastatic 
tumours secrete factors that alter normal brain endothelial cell func-
tion and may, in turn, enable the permeabilising effect of TNF on the 
BBB.
1. Connell JJ, Chatain G, Cornelissen B, Vallis KA, Hamilton A, 
Seymour L, Anthony DC, Sibson NR. Selective permeabilization 
of the blood–brain barrier at sites of metastasis. J Natl Cancer 
Inst. 2013; 105: 1634–43.
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While it is accepted that the neuron is the fundamental cell of the 
nervous system, it is increasingly appreciated that neurons work in 
concert with numerous other cell types including glia, pericytes, and 
endothelial cells as a neurovascular unit (NVU). The components of the 
NVU act together to ensure that neurons are able to respond quickly 
and efficiently to changes in input. This is achieved through control 
of metabolism, removal of waste, regulation of neurotransmitters, 
and responding to immunological and inflammatory insults. Though 
we know much about the molecular and physiological functions of 
individual parts of the NVU, there is less known about how the NVU 
directly affects behaviour. My aim is to study NVU function across its 
various components in relation to behaviour. Using RNA interfer-
ence, suppression of blood–brain barrier (BBB) tight junction proteins 
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occludin and claudin-5 provide insights on to the effects of BBB per-
meability on behaviour with claudin-5 suppression in particular 
showing a marked effect on learning and memory, anxiety, and social 
behaviour. Targeted claudin-5 suppression reveals region-specific 
effects on behaviour. Importantly, long-term claudin-5 suppression 
may provide a potential to understand not only normal brain function 
but also the progression of numerous neurological disorders. Beyond 
the BBB, implantable amperometric sensors allow for simultaneous 
measurements of changes in neurochemistry along with local field 
potential in freely-moving rodents—allowing for direct comparison 
between neuronal function and NVU activity. This allows for crucial 
insights into how supply and utilisation of metabolic substrates by the 
NVU relates to changes in behaviour.
Grant support: Science Foundation Ireland (12/ TIDA/I2308; 12/YI/
B2614; 11/PI/1080); Irish Research Council (GOIPD/2013/420); Bright-
Focus Foundation (A2015548S).
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The brain, including the blood–brain and the blood-CSF (choroid plexus) 
barriers, has a range of mechanisms that are induced by and limit injury. 
For example, intraventricular hemorrhage, a devastating component 
of germinal matrix hemorrhage in premature infants and intracerebral 
hemorrhage in adults, upregulates iron handling proteins at the choroid 
plexus. Hemoglobin-derived iron is a major cause of injury after cerebral 
hemorrhage and the induction of such proteins may limit choroid plexus 
injury. There is also an upregulation of proteins involved in CSF secretion 
at the choroid plexus and increased CSF secretion might help clear the 
intraventricular hematoma. However, if the CSF flow pathway is blocked, 
it may also lead to hydrocephalus. While endogenous protective mecha-
nisms can be induced after an injury, they can also be induced prior to 
injury by preconditioning stimuli. Preconditioning stimuli at the blood–
brain and blood-CSF barriers include brief periods of ischemia and phar-
macological agents such as isothiocyanates. Isothiocyanates, by inducing 
oxidative stress, activate the transcription factor nrf2, a master regulator 
of anti-oxidant defense mechanisms and thus induce many different 
proteins. The impact of current pharmacological strategies for treating 
stroke on endogenous neuroprotective mechanisms has received little 
attention. For example, do exogenous anti-oxidants prevent the activa-
tion of nrf2 and the upregulation of endogenous protective proteins? As 
endogenous neuroprotection involves multiple interlinked pathways, 
any negative impact of exogenous neuroprotectants on endogenous 
protection may serve to limit their effectiveness. Such effects may have 
contributed to the failure of many neuroprotectants that have gone into 
clinical trial for stroke.
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A number of peptide drugs for the treatment of brain diseases are 
available. However, to reach their target site of action, they must 
pass the blood–brain barrier (BBB). The capillary endothelium com-
prises the major physical barrier of the BBB and allows only pas-
sive permeation of molecules <400 Da. Brain delivery of the larger 
biopharmaceuticals, which today includes an increasing number of 
novel peptide-drug entities, is therefore restricted; both due to their 
large molecular size and hydrophilic nature. Thus, the development of 
peptide-drugs for the treatment of brain specific diseases requires a 
delivery strategy for overcoming the endothelial BBB in order to reach 
its final target within the brain.
The cell-penetrating peptides (CPPs) comprise a promising tool to 
facilitate delivery of macromolecular drug entities not only into cells 
but also across biological barriers, such as the BBB. The CPP Tat, an 
11-residue cationic peptide [1], has demonstrated potential as vector 
for brain delivery of the PSD-95 inhibitor NR2B9c, which hinders cell 
death following a stroke [2]. However, the mechanism by which Tat 
facilitates translocation of conjugated NR2B9c across the endothelial 
BBB is not known, and understanding the cellular events leading to 
Tat-membrane translocation likely lead to future development of opti-
mized CPP-peptide drug constructs.
In the present study the delivery propensity of Tat was assessed 
using a primary bovine BBB model [3] and the porcine epithelial 
IPEC J2 cell line displaying transepithelial electrical resistance val-
ues (>1000 Ω*cm2) comparable to the that of a tight BBB. Tat signifi-
cantly improved BBB translocation of NR2B9c across both the primary 
bovine BBB model as well as the IPEC J2 cell line. In order to explain 
the overall mechanism by which Tat facilitates NR2B9c barrier translo-
cation, being via endocytic uptake or direct membrane translocation, 
transport studies were conducted at temperatures <37°C (25°C, 4°C) 
or in the presence of sodium acid, which hinders energy-dependent 
endocytic uptake. Neither at low temperature nor in the presence of 
sodium acid Tat mediated transport of NR2B9c across the IPEC-J2 cell 
culture model; thus demonstrating endocytic uptake being involved. 
In addition, heparin pre-incubation, which binds heparan sulphates 
(HS) at the cell surface, hindered transport of the Tat-NR2B9c conju-
gate, therefore indicating that the initial binding of Tat to HS may be 
important for mediating endocytic uptake.
1. Vivès E, Brodin P, Lebleu B. A truncated HIV-1 Tat protein basic 
domain rapidly translocates through the plasma membrane and 
accumulates in the cell nucleus. J Biol Chem. 1997;272: 16010–
17.
2. Aarts M. Treatment of Ischemic Brain Damage by Perturb-
ing NMDA Receptor- PSD-95 Protein Interactions. Science. 
2002;298: 846–50.
3. Hans C Helms BB. Generation of primary cultures of bovine 
brain endothelial cells and setup of cocultures with rat astrocytes. 
Methods Mol Biol. 2014;1135: 205–11.
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The association of brain microvessels, astrocytes, pericytes, and neu-
rons constitutes the neurovascular unit (NVU), and the interplay 
between these cell types controls the properties of the blood–brain 
barrier (BBB). Brain capillaries have traditionally been viewed as tubes 
that passively conduct blood from the heart to active nerve cells, but 
recent studies suggest that mural cells on brain capillaries are much 
more active than previously thought. First order capillaries are the 
first to dilate during neuronal activity and pericytes constrict capil-
laries in cerebral ischemia, which is expected to promote brain dam-
age. However, the physiology of pericytes and brain capillaries is not 
completely understood and a number of important questions remain 
unanswered. For example, we know little about how capillaries com-
municate with one another to coordinate a blood flow response and 
the BBB tight and how this control affects the transport of nutrients 
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and drugs across the BBB. This talk will summarize novel findings using 
two-photon microscopy in vivo on how capillary flow and permeabil-
ity is controlled, how can it be quantified repeatedly in single and mul-
tiple capillaries in living mice.
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Dysfunction of the neuroprotective blood–brain barrier (BBB) and 
blood-cerebrospinal fluid barrier (BCSFB) and inflammation thereof are 
key events in multiple sclerosis (MS). In early stages of MS, inflammation 
of the brain barriers actively aids in immune cell influx, inducing neuro-
inflammation and demyelination. Upon MS progression, chronic BBB 
dysfunction is apparent, which contributes to gliosis and neurodegener-
ation. Moreover, barrier dysfunction goes hand in hand with a profound 
inflammation of the endothelial cells, thereby promoting infiltration 
of auto-reactive T-cells and monocytes, which further induces irrevers-
ible tissue damage. In turn, inflamed brain endothelium contributes to 
disease progression by its release of pro-inflammatory factors which 
activates the surrounding glia cells, together reinforcing astrogliosis, 
microglia activation and consequently neurodegeneration.
Our recent work suggests that under inflammatory conditions, brain 
endothelial cells (BECs) stimulate the migration of myelin-reactive 
T-cells by acting as non-professional antigen presenting cells through 
the processing and presentation of myelin-derived antigens in MHC-
II. Inflamed BECs internalized myelin which was routed to endo-lyso-
somal compartment for processing in a time-dependent manner and 
subsequently induce T-cell activation and migration. In the transmi-
gration of leukocytes across inflamed BECs, the enzyme acid sphin-
gomyelinase (ASM), involved in the production of bio-active lipids 
such as ceramide, is essential for the coordination of the function of 
the endothelial adhesion molecule ICAM-1. These results demonstrate 
that BECs are capable of enhancing antigen-specific T cell recruitment. 
Moreover, current treatment regimens for MS, such as dimethylfu-
marate, are capable of reducing immune cell trafficking through the 
induction of endogenous anti-oxidant enzyme systems.
Together this illustrates that identification of the pathways that coun-
teract BBB inflammation and reinstate proper BBB function will pro-
vide new and selective means to fight MS in different stages of disease.
Work was funded through grants of the Dutch MS research foundation
1. Lim JL, van der Pol SM, Di Dio F, van Het Hof B, Kooij G, de Vries 
HE, van Horssen J. Protective effects of monomethyl fumarate at 
the inflamed blood–brain barrier. Microvasc Res. 2016;105: 61–9.
2. Lopes Pinheiro MA, Kamermans A, Garcia-Vallejo JJ, et  al. 
Internalization and presentation of myelin antigens by the brain 
endothelium guides antigen-specific T cell migration. Westbrook 
GL, ed. eLife. 2016;5: e13149.
3. Lopes Pinheiro MA, Kroon J, Hoogenboezem M, Geerts D, van 
het Hof B, van der Pol SMA, van Buul JD and de Vries HE. Acid 
Sphingomyelinase–Derived Ceramide Regulates ICAM-1 Func-
tion during T Cell Transmigration across Brain Endothelial Cells. 
J Immunol. 2016;196: 72–9.
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Parkinsonism-dementia complex (PDC) is a neurodegenerative dis-
ease with Parkinsonism and early-onset Alzheimer-like dementia. 
PDC belongs to the family of neurodegenerative disorders known as 
tauopathies that are histopathologically characterized by abnormal 
deposition of microtubule-associated protein tau. While changes 
in the blood–brain barrier (BBB) in Alzheimer’s disease are increas-
ingly recognized, dysfunction of BBB in PDC has not been extensively 
studied. In present work we characterized cerebrovascular changes in 
patients with PDC.
Brain tissue from 10 postmortem PDC patients and 7 non-demented 
controls were assessed for structural and functional changes of BBB. 
Entorhinal cortex sections were immunostained for markers of brain 
endothelial cells (claudin-5, occludin and collagen IV) and inflamma-
tion (VCAM-1, ICAM-1, P-Selectin, E-Selectin). The ultrastructure of 
brain capillaries was investigated by confocal microscopy and mor-
phological changes and intensity alterations were evaluated. We 
found significant decrease of tight junction proteins and upregulation 
of adhesion molecules that correlates with the presence of neurofibril-
lary tangles. Additionally, we showed presence of  CD3+ and  CD4+ pos-
itive cells in brain areas affected by pathological lesions. Our findings 
indicate that pathological lesions in PDC are associated with inflam-
matory changes of brain capillaries and could mediate transmigration 
of cells to brain parenchyma.
This work was supported by APVV-14-0547 and VEGA 2/0159/15.
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The endothelial blood–brain barrier (BBB) maintains central nerv-
ous system (CNS) homeostasis and strictly controls T-cell traffick-
ing into the CNS. During multiple sclerosis (MS) or its animal model, 
experimental autoimmune encephalomyelitis (EAE), autoaggressive 
γ-interferon-producing  CD4+ Th1 or IL-17-producing  CD4+ Th17 enter 
the CNS causing neuroinflammation. The molecular mechanisms 
mediating Th1 cells migration across the BBB are quite well studied, 
and we could previously show that endothelial cell surface levels 
of ICAM-1 direct  CD4+ T cell to paracellular or transcellular sites for 
diapedesis. It has been suggested that Th17 cells may use different 
mechanisms from Th1 cells to extravasate. This prompted us to directly 
compare the cellular and molecular mechanisms used by those two 
 CD4+ T-cells subsets to cross the BBB.
Using primary mouse brain microvascular endothelial cells (pMBMECs) 
as an in  vitro BBB model, we compared the multi-step extravasation 
of in  vitro polarized myelin oligodendrocyte (MOG) transgenic T-cell 
receptor Th1 and Th17 cells by live cell imaging under physiologi-
cal flow. Our preliminary observations show higher numbers of Th1 
than Th17 cells arrested on pMBMECs under noninflammatory and 
inflammatory conditions, whereas Th17 cells have higher tendency to 
detach. After subsequent polarization, Th1 cells crawled with higher 
speed over the pMBMECs compared to Th17 cells. Similar numbers 
of diapedesis events were observed for both subsets. It remains to be 
shown if Th1 and Th17 cells cross the BBB preferentially via the para-
cellular or transcellular route. Thus, we have demonstrated that the 
dynamic interaction of Th1 cells with the BBB is distinguishable from 
that of Th17 cells. To analyse their potential molecular mechanism, we 
are currently comparing the trafficking molecule signature of both 
T-cell subsets by multi-parameter flow cytometry. To identify genes 
involved in regulating the cellular pathway of T-cell diapedesis across 
the BBB, we have performed RNAseq analysis from pMBMECs express-
ing high or low levels of endothelial ICAM-1 and thus favouring trans- 
versus paracellular T-cell diapedesis, respectively. After sequential 
selections, we have identified a set of candidate genes for biological 
validation.
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Identification of distinct molecular mechanisms mediating Th1 and 
Th17 cells’ migration across the BBB will allow us to accurately foresee 
CNS-specific adverse effects of the increasing numbers of therapies 
in many chronic inflammatory diseases targeting T-cell trafficking or 
even depleting peripheral T cells. Furthermore, our approach will allow 
us to identify novel therapeutic targets within the successful frame-
work of therapeutic targeting of immune cell trafficking to the CNS for 
the MS treatment.
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Efficient drug delivery across central nervous system (CNS) barriers is a 
central problem in pharmaceutical treatment of neurological diseases. 
Most pharmaceutical drug candidates including hydrophilic mol-
ecules, biopharmaceuticals, and efflux transporter ligands have a low 
permeability across the blood–brain barrier. Targeted nanoparticles 
are new tools to increase drug delivery to brain. The aim of our study 
was to compare different ligands of transporters present at the blood–
brain barrier for targeting vesicular nanoparticles. Non-ionic surfactant 
and cholesterol-based nanoparticles, so-called niosomes were derivat-
ized with alanin and glutathione using lipid or PEG linkers. The cargo 
of the niosomes was Evans blue-albumin complex. Treatments with 
niosomes did not influence the viability of primary rat brain endothe-
lial cells. The presence of targeting ligands on niosomes increased the 
uptake of the cargo molecule in cultured brain endothelial cells which 
could be visualized by confocal microscopy. The cellular uptake of 
niosomes was temperature dependent and could be decreased with 
sodium azide, a metabolic inhibitor indicating an active transport pro-
cess. Filipin and cytochalasin D, inhibitors of endocytosis decreased 
the uptake of the targeted nanoparticles in brain endothelial cells. The 
modifications of the charge of the endothelial glycocalix with TMA-
DPH (1- (1-(4-trimethylammoniumphenyl)-6-phenyl-1,3,5-hexatriene 
p-toluenesulfonate) or removing the glycocalyx with neuraminidase 
elevated the uptake of the targeted nanocarriers. Targeting ligands 
enhanced the permeability of the cargo across brain endothelial mon-
olayers. Treatment with niosomes increased plasma membrane fluidity 
in endothelial cells, suggesting the fusion of the nanovesicles with the 
cell membranes. Our data indicate that nutrient transporter ligands 
can potentially be exploited for CNS targeting of nanoparticles.
Supported by grants from the Hungarian Scientific Research Fund 
(OTKA PD105622), and the National Research, Development and 
Innovation Office (GINOP-2.2.1-15-2016-00007, GINOP-2.3.2-15-
2016-00060). S.V. was supported by the János Bolyai Research Fel-
lowship of the Hungarian Academy of Sciences (BO/00724/12). G.P. is 
a Szent-Györgyi student in the Szeged Scientists Academy Program 
of the Foundation for the Future of Biomedical Sciences in Szeged 
implemented with the support of the Ministry of Human Resources 
(TSZ:34232-3/2016/INTFIN).
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The blood–brain barrier (BBB) is formed by a layer of endothelial cells 
that line cerebral microvessels. Neighbouring endothelial cells are 
strongly attached to each other by tight junctions, which represent a 
physical barrier between the brain parenchyma and blood circulation. 
The integrity of the BBB ensures the ionic homeostasis necessary for 
the neuronal activity, correct flow of nutrients from the blood to the 
brain and prevents the entry of potentially harmful substances to the 
CNS. It is known, that the BBB changes are an integral part of many 
neurodegenerative diseases, including tauopathies. Tauopathies rep-
resent a heterogeneous group of neurodegenerative diseases charac-
terized by an abnormal deposition of microtubule-associated protein 
tau in cells of the central nervous system, such as Alzheimer´s disease, 
Down´s syndrome, progressive supranuclear palsy, Pick´s disease, cor-
ticobasal degeneration, frontotemporal dementia with Parkinsonism 
linked to chromosome-17, traumatic brain injury and others. To dem-
onstrate structural and functional changes of the BBB, suitable models 
and markers are required. Sodium fluorescein (SF) and Evans blue (EB) 
represent the most commonly used integrity tracers, despite their limi-
tations. In our study, we used SF as a marker for small molecules and 
EB for plasma proteins. While EB binds to plasma proteins to become 
a high molecular weight protein tracer, SF remains unbound in the 
blood stream. The concentration of SF in plasma and brain tissue sam-
ples was measured using Fluoroscan Ascent FL (485 nm/538 nm) and 
to monitor the extravasation of albumin across the BBB, we developed 
an ultrahigh-performance liquid chromatography method with UV 
detection (605 nm). Using these methods, we analysed the integrity 
of the BBB in transgenic rat model for tauopathies SHR-24 expressing 
human truncated tau (151-391) and age-matched control animals.
Acknowledgements: The authors would like to thank Axon Neuro-
science for providing the transgenic animals for this study. This work 
was supported by competitive academic grants VEGA 2/0159/15 and 
APVV-14-0547 and structural funds 26240220008, 26240220046.
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Alzheimer´s disease (AD) is a chronic neurodegenerative disease that 
damages the higher brain functions. Control of traffic of different 
substances between CNS and blood circulation is controlled by three 
barriers: arachnoid epithelium, blood–brain barrier (BBB) and choroid 
plexus epithelium (BCSFB). They represent highly dynamic system of 
cells and are involved in optimal brain functioning, synaptic transmis-
sion, synaptic remodeling, angiogenesis, neurogenesis etc. In case that 
barrier’s integrity is disrupted on any mode, many of vital brain func-
tions may be endangered. Today, we know that brain is not “immune 
privileged” and that many pathological states are involved in BBB 
breakdown and disorders, including AD. Better understanding of the 
anatomy and cell biology of these neurovascular units in health and 
disease is critical for advancement of therapeutic development.
While BBB being extensively studied, BCSFB has been largely under-
studied, but there are indications that its role is crucial in maintaining 
brain homeostasis, and even has a compensatory effect in case of BBB 
malfunctioning.
In our work we are focused on role of BCSFB in neurodegeneration. 
We showed presence of tau protein in epithelial cells of choroid plexus 
in animal model for tauopathy. We analyzed expression of transport 
proteins: LRP-1 and RAGE and showed changes in expression of pro-
inflammatory epithelial molecules. A thickening of epithelial basal 
membrane and greater collagen- IV depositions occurred around 
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capillaries in choroid plexus. These findings indicate structural and 
functional changes of choroid plexus in animal model for tauopathies.
This work was supported by competitive academic grants VEGA 
2/0159/15 and APVV-14-0547 and structural funds 26240220008, 
26240220046.
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Brain metastases are the most common brain neoplasms seen clini-
cally in the adults and comprise more than half of all brain tumors. 
Brain metastasis presents an emerging and urgent unmet medical 
need and that has been historically understudied. To evaluate brain 
metastatic process, our group has developed in  vitro blood–brain 
barrier (BBB) model and established the method of isolation and 
culture of primary cancer cells from human surgical specimens. Our 
model possesses the unique capability to examine brain metastases 
of human cancer cells and their therapeutic responses to chemo-
therapy. In our model, cancer cells were introduced to the luminal 
chamber. Cancer cells could pass through the BBB and drop onto the 
astrocytes in abluminal chamber. We observed the colony formation 
of cancer cells that expressed of specific tumor markers and reduction 
of transendothelial electrical resistance (TEER). The results also sug-
gest that the interactions between cancer cells and astrocytes in BBB 
microenvironment might affect the proliferation of cancer cells. Such 
primary human cancer cell cultures can serve as a model of choice for 
the study of the mechanisms behind key aspects of brain metastases 
biology, including metastatic process and drug testing. The goal of this 
study is to establish personalized treatment protocol for brain metas-
tases based on cell culture.
Grant support: This work was supported by JSPS KAKENHI Grant num-
ber 17K10840 and 15KK0349
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Drug abuse and addiction have been closely linked with HIV / AIDS 
because the infection easily spreads among drug abusers. Epidemio-
logical studies  on drug abusers with AIDS link cocaine abuse, more 
than other drugs, to acceleration of HIV infection and the progression 
of NeuroAIDS. Cocaine has been known to facilitate the transmigra-
tion of inflammatory leukocytes into the brain, which is an important 
mechanism for HIV entry into the central nervous system (CNS). Peri-
cytes, as important constituents of the blood–brain barrier (BBB), play 
a key role in maintaining the BBB integrity yet remain poorly studied 
in the context of CNS inflammation. In the present study, we demon-
strate that human brain vascular pericytes (HBVPs) exposed to cocaine 
manifest increased secretion of the chemokine IP-10, with a con-
comitant induction of monocyte transmigration across BBB both  in 
vitro  and  in vivo.  Furthermore, our findings demonstrated a time-
dependent translocation of NF-kB in HBVPs after cocaine-stimulation. 
Further dissection of NF-κB regulation using both the pharmacological 
and genetic approaches revealed that the NF-κB nuclear translocation 
was dependent on σ-1R, c-Src and PDGFR-β signal activation. Finally, 
our study demonstrated that IP-10 release was mediated by activation 
and translocation of sigma-1 receptor (σ-1R) and subsequent interac-
tion of σ-1R with c-Src kinase leading to activation of the Src-PDGFR-β-
NF-κB pathway and up-regulation of IP-10 expression. These findings 
implicate a novel role of IP-10 in the crosstalk of pericytes and mono-
cytes in cocaine-mediated neuroinflammation in the CNS, further 
underscoring the role of pericytes as active components of the innate 
immune responses.
Keywords:  IP-10, pericytes, cocaine, monocyte transmigration, 
sigma-1 receptor, blood–brain barrier
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Cerebral pericytes are mural cells embedded in the basement mem-
brane of capillaries. Increasing evidence suggests that they play impor-
tant role in controlling neurovascular functions, i.e. cerebral blood flow, 
angiogenesis and permeability of the blood–brain barrier. These cells 
can also influence neuroinflammation which is highly regulated by the 
innate immune system. Therefore, we systematically tested the pat-
tern recognition receptor expression of brain pericytes. We detected 
expression of NOD1, NOD2, NLRC5, NLRP1-3, NLRP5, NLRP9, NLRP10 
and NLRX mRNA in non-treated cells. Among the ten known human 
TLRs, TLR2, TLR4, TLR5, TLR6 and TLR10 was found to be expressed. 
Inflammatory mediators induced the expression of NLRA, NLRC4 and 
TLR9 and increased the levels of NOD2, TLR2, inflammasome-forming 
caspases and inflammasome-cleaved interleukins. Oxidative stress, on 
the other hand, upregulated expression of TLR10 and NLRP9. Activation 
of selected pattern recognition receptors can lead to inflammasome 
assembly and caspase-dependent secretion of IL-1β. TNF-α and IFN-γ 
increased the levels of pro-IL-1β and pro-caspase-1 proteins; however, 
no canonical activation of NLRP1, NLRP2, NLRP3 or NLRC4 inflammas-
omes could be observed in human brain vascular pericytes. On the 
other hand, we could demonstrate secretion of active IL-1β in response 
to non-canonical inflammasome activation, i.e. intracellular LPS or 
infection with E. coli bacteria. Our results indicate that pericytes might 
have an important regulatory role in neuroinflammation.
Grant support: This work was supported by the National Research, 
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2.3.2-15-2016-00001). Á.N-T. was supported by the Doctoral Scientific 
Scholarship of the Doctoral Institute of University of Szeged and by the 
ÚNKP-16-3/1. VI. 2. New National Excellence Program of the Ministry 
of Human Capacities. I.W. was supported by the János Bolyai Research 
Fellowship of the Hungarian Academy of Sciences (BO/00334/16/8).
A44 
Dynamic blood brain barrier regulation in sub‑concussive brain 
injuries
Eoin O’Keefe1, Eoin  Kelly2, Eugene  Wallace2, Chris  Greene1, Stephanie 
 Hughes3, John  Kealy1, Niamh  Doyle3, Marian M.  Humphries1, Michael 
 Farrell4, Gerald A.  Grant5, Alon  Friedman6,7, Ronel  Veksler6, Michael G. 
 Molloy8, James F.  Meaney9, Niall  Pender3, Colin P.  Doherty2 and Matthew 
 Campbell1
1Smurfit Institute of Genetics, Trinity College Dublin, Dublin 2, Ireland., 
2Department of Neurology, Health Care Centre, Hospital 5, St James’s 
Hospital, Dublin 8, Ireland., 3Department of Psychology, Beaumont 
Page 17 of 23Fluids Barriers CNS 2017, 14(Suppl 2):27
Hospital, Dublin 9, Ireland, 4Department of Neuropathology, Beaumont 
Hospital, Dublin 9, Ireland., 5Department of Neurosurgery, Stanford 
University School of Medicine, Stanford, California, USA., 6Department 
of Cognitive and Brain Sciences, Zlotowski Center for Neuroscience, 
Ben‑Gurion University of the Negev, Beer‑Sheva, Israel., 7Department 
of Medical Neuroscience, Dalhousie University, Halifax, Canada., 
8Department of Medicine, University College Cork, Cork, Ireland., 
9Department of Radiology, St James’s Hospital, Dublin 8, Ireland.
Correspondence: Eoin O’Keefe (eookeeff@tcd.ie)  
Fluids and Barriers of the CNS 2017, 14(Supp 2):A44
Traumatic brain injury (TBI) continues to be a global a health issue, con-
tributing to the deaths of thousands and the debilitation of many more 
each year. While moderate and severe TBI may be recognised by overt 
symptoms or abnormalities on conventional imaging modalities (MRI 
or CT scans), injuries categorised as mild, injuries commonly referred 
to as concussions, rely on individual neuropsychological assessments. 
While undetected by current neuroimaging paradigms, subtle changes 
in the gliovascular unit that may following mild or sub-mild TBI may 
contribute to development of neurodegenerative conditions later in 
life, as suggested by findings of Blood Brain Barrier disruption (BBBD) 
in an individual diagnosed with Chronic Traumatic Encephalopathy, a 
condition primarily associated with repeated mild TBI.
Here we present evidence of changes at the Blood Brain Barrier in a sub-
set of children following a season of Rugby Union, measured by Gado-
linium extraversion signal. Paired with this were findings of increased 
levels of BDNF and MCP-1 in plasma samples, in addition to increased 
pro-inflammatory response by Peripheral Blood Mononuclear Cells post-
season, as measured by IL- 1β production following necrotic brain tissue 
stimulation. In addition, examining a young adult cohort produced simi-
lar finding when examined within hours of engaged in a Rugby Union 
match. These finding suggest that a combination of analytical methods 
are required in order to gain an understanding of potential neural dam-
age occurring due to mild TBI or sub-concussive blows.
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There is no effective therapeutic intervention developed targeting 
cerebrovascular toxicity of drugs of abuse, including methampheta-
mine (METH). We hypothesize that exercise can protect against METH-
induced neurotoxicity by enhancing the blood–brain barrier (BBB) 
integrity and protection against aberrant hippocampal neurogenesis. 
To address this notion, mice were administered with METH for 5 days 
with an escalating dose regimen, followed by voluntary wheel run-
ning for 2 weeks resembling the voluntary pattern of human exercise. 
The frequency, duration, and intensity of each running session were 
monitored for each mouse via a direct data link to a computer and the 
running data are analyzed by Clocklab™ Analysis software. Controls 
included sedentary mice that did not have access to running wheels 
and/or were injected with saline. METH administration disrupted 
hippocampal neurogenesis by inducing aberrant differentiation of 
neural progenitor cells to both immature and mature neurons. In addi-
tion, METH increased hippocampal BBB permeability by disrupting 
expression and localization of tight junction proteins. These changes 
were preserved in sedentary mice; however, exercise significantly 
attenuated METH-induced aberrant neurogenesis and disruption of 
the BBB integrity. Importantly, abnormal neurogenesis observed in 
METH-treated mice was associated with alternations of spatial mem-
ory as evaluated by Morris water maze. These behavioral changes were 
also attenuated by exercise. Overall, our results indicate that physical 
exercise can protect against METH-induced alterations of neurogen-
esis presumably by stabilization of the BBB.
Grant support: This work was supported by the NIH, grants DA039576, 
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2015/17/B/NZ7/02985.
A46 
Cellular interactions in the neurovascular unit during brain 
development
Ana Pombero, Raquel Garcia‑Lopez, Marta Martinez‑Morga and Salvador 
Martinez
Instituto de Neurociencas de Alicante, Alicante, Spain
Correspondence: Salvador Martinez (smartinez@umh.es)  
Fluids and Barriers of the CNS 2017, 14(Supp 2):A46
Neurogenesis and angiogenesis are processes that occur at the same 
time during brain development. Neurogenesis is a basic process 
occurring during embryonic development that proceeds throughout 
the adult life in the neurogenic areas, such as subventricular zone and 
the subgranular zone of the dentate gyrus (DG). In the DG the main-
tained neurogenesis represents a structural and functional singular-
ity, which may determine its complex vascular pattern. Neurogenesis 
and angiogenesis share molecular signals and are mutually promotive, 
which support the concept of neurogenic niche in the brain, a func-
tional unit between the precursor cells and their local microenviron-
ment, in which blood vessel represent a key element. Whereas it is 
well-known that vascular development controls proliferation during 
brain development and in the adult by neurotrophic factors release, 
it still remains elusive how neural cells signal to vascular components 
during angiogenesis. We have demonstrated that the reduction of 
neural progenitor cells leads to an important impairment of the vas-
cular development together with a reduction of the quantity of prolif-
erating cells near blood vessels. Since VEGF is a potential regulator in 
neurogenesis and angiogenesis crosstalk, we are interested in assess 
the potential role of this molecule in the hippocampal neurovascular 
niche. Our results point out that neural progenitors secrete VEGF-A to 
regulate the vascular development in the dentate gyrus.
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The microvascular endothelial cells in the brain, connected by tight 
junctions, are surrounded by pericytes, astrocytes, microglia and 
neurons. Together they act as a functional unit, named the neu-
rovascular unit (NVU). Proper functioning of the NVU in general is 
critical for normal brain functions and homeostasis. Accumulated 
recent data from human and animal studies reveal that increased 
permeability of the blood–brain barrier (BBB) is a major determi-
nant in common neurological disorders. We have previously shown 
that long-lasting dysfunction of the BBB leads to astrocytic trans-
formation and epileptogenesis [1, 2, 3, 4]. Inversely, vascular injury 
and specifically BBB dysfunction are well-documented outcomes of 
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epileptic seizures. However, the detailed endothelial pathology and 
mechanisms underlying increased permeability of the BBB are poorly 
understood. Here we will present recent data, directing for the role 
of neuronal-enhanced glutamate release and NMDA-receptors in 
seizure-induced opening of the BBB [5]. We will next describe our 
recent studies on the key role of NVU interactions in the regulation 
of oxygenated-blood supply to the metabolic demand of activated 
brain cells (“neurovascular-coupling”). As pericytes were described to 
have an important role in the integrity of the BBB, we will show that 
recurrent seizures are associated with pericytic injury and BBB dys-
function, and result with impaired vascular response to seizures at 
both capillary and arteriolar levels. Finally, we will discuss new data 
suggesting endothelial pathology as a diagnostic and treatment tar-
get for brain disorders [6, 7].
Grant support: European Union’s Seventh Framework Program (EU, 
FP7), DFG and EXC Neurocure grants. NIH Israel Science Foundation 
(ISF), German Science Foundation (DFG), the CURE Epilepsy Founda-
tion, the Nova Scotia Health Research Foundation and Canada Insti-
tute for Health Research (CIHR).
1. Seiffert E, Dreier JP, Ivens S, Bechmann I, Tomkins O, Heine-
mann U, Friedman A. Lasting blood–brain barrier disruption 
induces epileptic focus in the rat somatosensory cortex. J Neuro-
sci. 2004;24:7829–36.
2. Ivens S, Kaufer D, Flores LP, Bechmann I, Zumsteg D, Tomkins 
O, Seiffert E, Heinemann U, Friedman A. TGF-β receptor-medi-
ated albumin uptake into astrocytes is involved in neocortical 
epileptogenesis. Brain. 130: 535–47.
3. Cacheaux LP, Ivens S, David Y, et  al. Transcriptome Profiling 
Reveals TGF-β Signaling Involvement in Epileptogenesis.  The 
Journal of neuroscience : the official journal of the Society for 
Neuroscience. 2009;29(28):892–35.
4. Bar-Klein G, Cacheaux LP, Kamintsky L, et al. Losartan prevents 
acquired epilepsy via TGF-β signaling suppression. Ann Neurol. 
2014;75: 864–75.
5. Vazana U, Veksler R, Pell GS, et al. Glutamate-Mediated Blood–
Brain Barrier Opening: Implications for Neuroprotection and 
Drug Delivery. J Neurosci. 2016;36: 7727–39.
6. Bar-Klein G, Klee R, Brandt C, Bankstahl M, Bascuñana P, Töll-
ner K, Dalipaj H, Bankstahl JP, Friedman A, Löscher W. Isoflu-
rane prevents acquired epilepsy in rat models of temporal lobe 
epilepsy. Ann Neurol. 2016;80: 896–908.
7. Bar-Klein  G, Lublinsky S, Kamintsky L, Noyman I, Veksler R, 
Dalipaj H, Senatorov VV Jr, Swissa E, Rosenbach D, Elazary N, 
Milikovsky DZ, Milk N, Kassirer M, Rosman Y, Serlin Y, Eisen-
kraft A, Chassidim Y, Parmet Y, Kaufer D, Friedman A. Imaging 
blood–brain barrier dysfunction as a biomarker for epileptogen-
esis. Brain. 2017;140: 1692–1705
A48 
The neuroprotective role of physical exercise
Zsolt Radak
University of Physical Education, Budapest, Hungary
Correspondence: Zsolt Radak (radak@tf.hu)  
Fluids and Barriers of the CNS 2017, 14(Supp 2):A48
Regular exercise has systemic beneficial effects, including the promotion 
of brain function. The adaptive response to regular exercise involves the 
up-regulation of the enzymatic antioxidant system and modulation of 
oxidative damage. Reactive oxygen species (ROS) are important regula-
tors of cell signaling. Exercise, via intensity-dependent modulation of 
metabolism and/or directly activated ROS generating enzymes, modu-
lates the cellular redox state of the brain. ROS are also involved in the 
self-renewal and differentiation of neuronal stem cells and the exercise-
mediated neurogenesis could be partly associated with ROS produc-
tion. Regular physical exercise and nutritional intervention decrease 
both the incidence and symptom intensity of Alzheimer’s disease (AD) 
and modulate microbiome. When APP/PS1 mice were subjected to exer-
cise and probiotics they significantly outperformed controls, whereas 
exercise, prebiotics alone and the two together resulted in decreases 
in beta-amyloid plaques, and increased microglia numbers around the 
plaques. Moreover, data also showed that exercise training increased 
the levels of anti-inflammatory microorganisms, such as bacteria that are 
involved in butyrogenesis. Overall, it is clear that physical exercise exerts 
neuroprotective effects on brain via complex mechanisms.
Exercise has strong effects on the immune system and readily alters 
the production of cytokines. Certain cytokines, especially IL-6, IL-1, 
TNF-a, IL-18 and IFN gamma, are actively involved in the modulation of 
synaptic plasticity and neurogenesis. Cytokines can also contribute to 
ROS production. ROS mediated alteration of lipids, protein, and DNA 
could directly affect brain function, while exercise modulates the accu-
mulation of oxidative damage. Oxidative alteration of macromolecules 
can activate signaling processes, membrane remodeling, and gene 
transcription. The well-known neuroprotective effects of exercise are 
partly due to redox- associated adaptation.
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The choroid plexi (CP) are highly vascularised projections of the brain 
ventricles that act as barriers between the blood and the cerebrospinal 
fluid (CSF), forming the blood-CSF-barrier (BCSFB). Their best known 
function is to produce CSF, but increasing evidence indicates CP are 
also involved in the maintenance of immune homeostasis of the cen-
tral nervous system (CNS), thereby indirectly regulating immune cell 
entry into the CNS. Multiple sclerosis (MS) is an autoimmune demyeli-
nating disease of the CNS characterized by chronic inflammation and 
neurodegeneration. We hypothesise that, due to its essential function, 
a dysregulation of the CP could contribute to MS pathology.
To reveal potential alterations in the CP associated with MS, we per-
formed RNA-sequencing on human post-mortem CP derived from the 
lateral ventricles of 6 progressive MS patients and 6 non-neurological 
controls. Total RNA was isolated and only samples with good quality 
RNA (RIN > 7) were selected, enriched by rRNA depletion and used for 
paired-end sequencing.
Significant alterations in the CP transcriptome were identified which 
predominantly revealed pathways involved in cell migration, adhe-
sion, inflammation, angiogenesis, and oxidative stress. We identi-
fied 14 genes differentially expressed (padj < 0.05, baseMean > 50) 
between the MS and the control CP.
Further validation and functional studies of the identified genes will 
shed light on the specific roles of the CP in MS. The identification of CP 
specific pathways contributing to MS pathogenesis will provide novel 
insights into the disease and may yield new targets for treatment.
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The motivation of our study is the actual problem in neurosciences as 
the development of methods for the brain drug delivery, which can 
open the door of progress to the therapy of central nervous systems 
diseases. There are more than 70 technologies for overcoming of the 
blood–brain barrier (BBB). However, no one of them is widely used in 
daily clinical practice due to invasiveness, limitation of treatment area 
or drug concentration and other complications.
This study is focused on the development of new non-invasive 
method for the reversible opening of BBB by sound (110 dB, 370 Hz, 
duration 2h), which is usual for daily life in modern big cities.
The independent ex  vivo and in  vivo results on mice obtained in 
twelve different research groups clearly demonstrate that sound sig-
nificantly increases the BBB permeability to both high and low molec-
ular weight substances as well as to liposomes (100 nm) that mimics 
the delivery into the brain solutes, proteins and nanocarrier materials. 
The physiologists, chemists, and physicists studied the effectiveness 
of sound to open the BBB and mechanisms underlying these process 
using classical and modern approaches in the assessment of the BBB 
permeability and cerebral microcirculation, such as confocal and mag-
netic resonance imaging, two photon microscopy, spectrofluorometric 
assay. The safety and reversibility of non-invasive effects of sound on 
the BBB permeability were confirmed by histological analysis of the 
brain tissues and vessels on the large groups of mice that as evaluated 
by qualified anatomists.
Thus, sound as natural factor due to its high effectiveness and easy 
execution has good perspective to be widely introduced in daily clini-
cal practice for successful brain drug delivery.
This work was supported by Grant of Russian Science Foundation № 
17-15-01263.
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The blood brain barrier (BBB) is a barrier that protects the brain against 
various harmful substances. However, it is an important limitation for 
the development of new drugs. For this reason, there is a constant 
search in find new alternatives to deliver drugs to the brain. In this 
way, polymeric nanoparticles (NPs) from (D,L-lactide-co-glycolide) 
poly(ethylene glycol) (PLGA-PEG) could be an important strategy 
to facilitate the transport of therapeutic molecules across the BBB; 
they are a drug delivery systems that is biodegradable, biocompat-
ible and approved by Food and Drug Administration (FDA). The main 
objective of this work was the encapsulation of an anti-diabetic drug 
in polymeric NPs of PLGA-PEG to analyze its toxicity and internaliza-
tion using a human brain microvascular endothelial cell line (hCMEC/
D3). The NPs were prepared by the solvent displacement technique. 
An initial study used a factorial design to modify the independent 
variables determining NP synthesis. Subsequently, physicochemical, 
biopharmaceutical and stability characterization studies were done. 
To evaluate the toxicity and uptake, NPs, at concentrations up to 10 
µg/mL, were applied to the hCMEC/D3 cell line. Uptake was measured 
by flow cytometry (FACSCalibur) with rhodamine-labelled NPs. The 
experiment was standardized to 10,000 events on the gate and at volt-
age of 410 mV with respect to the control sample (untreated cells). The 
results demonstrated that the NPs (mean size around 160 nm and neg-
ative charge of −14.4 mV), were internalized by the cells, and showed 
the character of a monodisperse systems. The release profile showed 
a slow release with a Fick’s passive diffusion. In the toxicity assay, cells 
were 80% viable up to a concentration of 5 µg/mL. Fluorescence and 
electron microscopy indicated that NPs were primarily present in the 
cells’ cytosol. Taken together, the results demonstrate that these nan-
oparticles could be effective in delivering therapeutics to the central 
nervous system.
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According to the neurovascular hypothesis, impaired clearance of 
the amyloid-beta (Aβ) peptide across the blood–brain barrier (BBB) 
contributes to Alzheimer’s disease (AD) pathology. However, conflict-
ing findings on the involvement of different Aβ transporters at the 
BBB and their expression in brain endothelium have questioned the 
role of LRP1 and Pgp at the BBB. As global knockout of Lrp1 in mice 
is lethal, there is a lack of appropriate models to study the function 
of LRP1. Moreover, the relevance of systemic Aβ clearance remains 
unclear as no BBB-specific knockout models had been available. We 
used in vitro and in vivo methods to quantify the rate of Aβ clearance 
across the BBB. With a novel Slco1c1-CreERT2 mouse, we generated 
the first brain endothelial-specific Lrp1 knockout mouse to accurately 
evaluate LRP1-mediated Aβ BBB-clearance in vivo. Using stereotactical 
injections of physiological concentrations of radiolabeled Aβ peptides, 
we were able to quantify the rate of LRP1-mediated clearance at the 
BBB in  vivo. Crossing the LRP1 KO mice to the 5xFAD mouse model 
resulted in reduced plasma Aβ and elevated soluble brain Aβ leading 
to aggravated spatial learning and memory deficits, thus, emphasizing 
the importance of systemic Aβ elimination via the BBB. By combining 
primary mouse brain endothelial cells from these animals with Pgp 
inhibitors, we are able to identify the role of each transporter at the 
BBB for Aβ clearance in  vitro. Dissecting the function of these trans-
porters may provide new approaches for treatment and prevention of 
Aβ brain accumulation in AD.
Grant support: This work was supported by the EU Joint Programme—
Neurodegenerative Disease Research (JPND) project (PROP-AD J.P. and 
C.U.P.) and the DFG (J.P. and C.U.P.)
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Perfluoroalkyl substances (PFASs) are classified as persistent and biac-
cumulative substances. They are metabolites of several polyfluorinated 
precursor compounds that are produced and used commercially. 
PFASs have been detected globally as pollutants in water, plants, food-
stuffs, and in fish, birds, in mammals’ tissues as well as in human breast 
milk and blood. Moreover, they have been found in wildlife samples 
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from all over the world thus suggesting their bio-accumulation in 
higher trophic levels in the food chains.
In this study, the possible PFASs bioaccumulation in tissues of animal 
origin was addressed with special focus on their ability to across the 
blood–brain barrier. Determination of selected perfluoroalkyl carbox-
ilic acids (PFCAs) and perfluoroalkane sulfonates (PFSAs) concentra-
tion was performed in subcutaneous adipose and peritoneum tissues, 
internal organs (brain, liver) and tail tissue of free-living European bea-
ver (Castor fiber L.) in Masurian Lakeland (NE Poland).
In a group of ten selected perfluoroalkyl substances only two per-
fluoroalkyl carboxilic acids (PFOA and PFNA) and one perfluoroalkane 
sulfonate (PFOS) were quantified. PFOA was detected in all analysed 
tissue samples in both female and male beavers in a range from 0.55 
to 0.98 ng  g−1 ww whereas PFOS was identified in all analyzed female 
beaver tissues and only in liver, subcutaneous adipose and  perito-
neum tissues of male beavers at the concentration level from 0.86 to 
5.08 ng  g−1 ww. PFNA was only identified in female beaver tissues 
(liver, subcutaneous adipose and peritoneum) in a range from 1.50 to 
6.61 ng  g−1 ww.
In this study for the first time, the accumulation of PFOA in brain tissue 
of beavers was shown. This finding may suggest the ability of PFOA to 
across the blood–brain barrier but the potential impact of this phe-
nomenon in beavers is still unknown. In contrast, PFOS has limited 
potential to cross the  blood–brain barrier since this compound was 
only detected in one beaver. We presume that the results of the pre-
sent study, although of basic and preliminary character, demonstrate 
the bio-accumulation of PFOA, and to lesser extent PFOS and PFNA, in 
tissue samples collected from both female and male beavers living in 
area known as green lungs of Poland.
This research was performed within the EU project REFRESH 
(FP7-REGPOT-2010-1-264105).
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In sheep, the concentrations of leptin in blood plasma and the cer-
ebrospinal fluid (CSF) are photoperiodically differentiated, increase in 
long days (LD) and decrease in short days (SD). Moreover, there is also 
photoperiodic differentiation in hypothalamic sensitivity to leptin that 
administered intracerebroventricularly suppresses appetite in SD but 
not LD. There is abundant expression of short isoform of leptin recep-
tor (Ob-Ra) in the choroid plexus (CP) linked with leptin entry into CSF 
and lower expression of long isoform (Ob-Rb), a primary functional 
isoform. Moreover, most of the immune cells infiltrating CP during 
inflammation express Ob-Rb. Considering modulatory effect of leptin 
on inflammatory response and angiogenesis we hypothesized that 
leptin modulates CP response to immune stress and that this effect is 
photoperiodically differentiated.
Studies were performed on adult ewes kept in natural LD (n=24) and 
SD (n=24), treated with: saline (control), LPS (400 ng/kg), leptin (20 μg/
kg) and LPS/leptin. Ewes were sacrificed 3 h after LPS/saline and 2.5 h 
after leptin/saline. Leptin receptors mRNA expression (Ob-Ra, Ob-Rb) 
and Ob-Rb activation pathway (Jak2, Stat3, Socs3), Toll-like receptors 
(Tlr2, Tlr4), cytokines and their receptors (Il1B, Il1r1, Il1r2, Il1ra, Il6, Il6st), 
chemokine (Ccl2) and factors linked with CSF secretion: aquaporin 1 
(Aqp1), Claudin-2 (Cldn2) and system of vascular endothelial growth 
factor (Vegf, VegfR1, VegfR2) were analyzed by qPCR. Reactions on pho-
toperiod and treatments were monitored by serum level of prolactin, 
cortisol and leptin.
Changes in leptin receptors were observed only during SD, when lep-
tin did not affect but LPS reduced (p<0.05) mRNA expression of Ob-
Rb. CP responded on LPS treatment, through mRNA elevation of all 
examined cytokines/cytokines receptors and chemokine, but for Tlr2, 
Il1B, Il1R1, Il1Ra, Il6 and Socs3 this reaction was significantly higher dur-
ing SD vs. LD. Leptin increased (p<0.05) the response of CP to immune 
stress for Il1r2, Il1ra, Il6, Il6st, Ccl2, Jak2 and Socs3, during LD and Il1B 
during SD. LPS treatment decreased expression of Cldn2 in SD and LD. 
Leptin did not affect Aqp1 and Cldn2. In case of VEGF/VEGFR system, 
the impact of LPS and leptin was photoperiodically differentiated. LPS 
did not affect Vegf120 and Vegf164, however increased (p<0.05) VegfR1 
and VegfR2 but only in SD. In SD leptin increased (p<0.05) Vegf164 and 
VegfR1 and increasing tendency was observed for Vegf120 (p= 0.06). 
During LD VegfRs increased only in leptin/LPS group. This results, 
confirmed hypothesis that leptin modulates CP response to immune 
stress in photoperiodically differentiated way.
Funded by the National Science Centre of Poland, grant SONATA no 
2013/11/D/NZ9/02536. Participation of AS, MK and JS was supported 
by statutory research founds of Ministry of Higher Education.
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Activation of hypoxia inducible factor-1 (HIF-1) is crucial for cells to 
adapt to hypoxic/ischemic stresses. For decades, HIF-1 stroke research 
has mainly been limited to neurons with stabilization of HIF-1 sug-
gested as a potential neuroprotective strategy. However, successful 
employment of such strategy means the impact of HIF-1 induction 
on non-neuronal cells needs to be thoroughly understood during cer-
ebral ischemia. Pericytes play a key regulatory and structural role in 
the ischemic blood–brain barrier (BBB). However, the consequences of 
altered pericyte HIF-1 signaling during stroke remain unknown.
Recently, we have generated a mouse line with pericyte-targeted 
HIF-1α knockout (KO) under the control of the inducible Cre/Lox 
system. The mouse line enables us to specifically explore effects of 
pericyte-mediated HIF-1 signaling on stroke outcome and BBB mod-
ulation after ischemic insult. We subjected pericyte HIF-1 KO and WT 
mice to transient middle cerebral artery occlusion (tMCAo) for 45 mins 
using intraluminal filament method followed by reperfusion up to 14 
days. Ischemic damage, BBB permeability, neurological scores were 
assessed. Intriguingly, our data suggested stabilization of HIF-1 in 
pericytes differentially modulates barrier integrity and stroke outcome 
during stroke progression. Firstly, at 72h post-tMCAo HIF-1 deletion 
reduced IgG extravasation and Evans blue leakage. Although overall 
infarct volume was unaffected, reduced neuronal degeneration, less 
cell apoptosis and more astrocyte activation were observed in HIF-1 
KO peri-infarct cortex by immunostaining. Therefore, HIF-1 deletion 
preserves barrier integrity and improves stroke outcome at the suba-
cute stage. Surprisingly however, at 14 days reperfusion, reversal of 
positive effects of HIF-1 deletion was seen. HIF-1 KO mice exhibited 
higher blood vessel density compared to WT controls in correlation 
with increased permeability. Furthermore, enhanced brain shrinkage 
and Flurojade C-positive processes were observed in KO mice. Taken 
together, our results highlight a time-dependent effect of pericyte 
HIF-1 stabilization on BBB regulation after insult. The switch from 
maintenance of vascular homeostasis to negative outcome suggests a 
therapeutic time window should be considered when targeting HIF-1 
for stroke therapy.
Grant support: Swiss National Science Foundation grant (31003A_150062) 
to Omolara Ogunshola
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HIV associated neurocognitive disorders (HAND) develop in >50% 
of HIV infected individuals, despite successful combined antiret-
roviral therapy (cART). HAND is mediated by mature  CD14+CD16+ 
monocytes that transmigrate across the blood–brain barrier (BBB) 
in response to CCL2, a chemokine highly elevated in the CNS of HIV 
infected people, and establish viral reservoirs and an inflammatory 
and toxic environment in the CNS, leading to HIV neuropathogen-
esis. Our laboratory showed that transmigration of mature mono-
cytes across the BBB is significantly greater in people with HAND 
than those without HAND, in part due to increased expression of 
CCR2, the CCL2 receptor. Additionally our laboratory showed the 
junctional proteins JAM-A and ALCAM are significantly increased on 
mature monocytes of HIV-infected people, and that these proteins 
are essential to transmigration across the BBB. We now show for the 
first time in HIV-infected individuals by FACS detection of cells that 
are infected with HIV,  HIV+CD14+CD16+ monocytes, and cells that are 
not infected but that have been exposed to viral proteins and inflam-
matory mediators,  HIVexpCD14+CD16+ monocytes. We demonstrate 
that  HIV+CD14+CD16+ monocytes express higher JAM-A and ALCAM 
than  HIVexpCD14+CD16+ monocytes. Additionally, we demonstrate 
that primary human  HIV+CD14+CD16+ monocytes preferentially 
transmigrate across the BBB in response to CCL2 in comparison to 
 HIVexpCD14+CD16+ monocytes. We propose that this is mediated, in 
part, due to increased JAM-A, ALCAM, and CCR2 on the  HIV+ mature 
monocytes. Antibodies against JAM-A and ALCAM, and the novel 
CCR2/CCR5 dual inhibitor cenicriviroc, prevented or significantly 
reduced preferential transmigration of  HIV+CD14+CD16+ monocytes. 
This indicates that JAM-A, ALCAM, and CCR2 may be potential thera-
peutic targets to block entry of these infected cells into the brain, and 
prevent or reduce the establishment and replenishment of viral reser-
voirs within the CNS, resulting in decreased neuroinflammation, toxic-
ity, and HAND.
This work was supported by U.S. National Institutes of 
Health Grants R01MH075679 (J.W.B.), R21MH102113-01A1 
(to J.W.B), R01MH090958 (J.W.B.), 1R01MH112391 (J.W.B), 
U24MH100931 (Manhattan HIV Brain Bank), P30AI124414 (Einstein-
Rockefeller-CUNY Center for AIDS Research), TL1TR001072 (Einstein-
Montefiore CTSA), and by the eCLIPSE program fellowship supported 
by the Burroughs Wellcome Foundation Grant program “Unifying 
Population and Laboratory Science”(MV).
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Small extracellular vesicles (EVs), including microvesicles (origi-
nated from the plasma membrane) and exosomes (originated in the 
endocytic pathway), have emerged as central players in intercellular 
communication. They are released into the extracellular space by 
almost every cell type and can functionally regulate target cells due 
to their bioactive cargo (i.e. proteins, lipids, nucleic acids and carbo-
hydrates), which varies under different physiological or pathological 
conditions. However, the EV-mediated bi-directional communication 
between the CNS and the vascular system remains enigmatic, as well 
as the regulation of this process under chronic stress. We have focused 
on astrocyte-derived EVs and their interaction with and effects on 
immature neurons, neural precursors, and their possible transfer to 
the blood. Besides typical EV markers (such as CD63, TSG101, flotillin), 
astrocyte-derived EVs contain microRNA 26a (miR26a) and aldolase C, 
a glycolytic enzyme expressed selectively in forebrain astrocytes. We 
have used in utero electroporation of rat brains to transfer aldolase 
C-GFP to astrocytes. Interestingly, the tagged enzyme is detected not 
only in CSF-derived EVs but also in blood serum-derived EVs. Moreo-
ver, the protein cargo of serum EVs, including aldolase C and Glial 
Fibrillary Protein (GFAP), varied under selective stress conditions. 
The EV-mediated transfer of aldolase C-GFP and of miR26a to imma-
ture neurons had morphological consequences that were mediated 
by miR26a while its transfer to neural precursor cells and endothelial 
cells is under study. Thus, in vivo and in vitro studies show that brain-
derived EVs can be transferred through brain barriers into the blood. 
Conversely, blood-borne EVs can reach the neural tissue thus acting as 
major regulators of brain function. The potential EV-mediated trans-
fer of signals from the periphery to adult neurogenic niches could be 
explored in the future with therapeutic purposes.
Acknowledgements: Fondecyt 1140108 (UW) and 1141015 (LFB)
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Although there are many antiepileptic drugs currently used for the 
treatment of epilepsy, drug resistance is still a main problem with the 
underlying mechanisms still poorly understood. One of the major rea-
sons for the failure of antiepileptic drugs in resistant epilepsy is the 
blood–brain barrier (BBB). In this study, temporal lobe epilepsy (TLE) 
was induced in adult Wistar rats using kainic acid. Glucose coated 
gold nanoparticles (GNP) were loaded with lacosamide (LCD) and 
labeled with a fluorescent probe and presented into the circulation 
to be transported into the brain for treatment. The amount of GNP in 
the brain tissue was measured with inductively coupled plasma mass 
spectrometry, and fluorescent signals were observed by in vivo imag-
ing. Electroencephalography (EEG) was recorded from the hippocam-
pus of animals. Electron microscopic evaluation was performed to 
show GNP in the brain parenchyma. The main amplitude of the EEG 
records returned to the basal values right after GNP-LCD administra-
tion in animals with TLE. A time-related increase in the fluorescent sig-
nals was observed by GNP-LCD injection in the brains of animals with 
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TLE. When the amount of GNP either loaded or not loaded with LCD 
was measured in the brain parenchyma of animals with or without TLE, 
the amount of GNP not loaded with LCD was found to be significantly 
higher in animals with TLE (p<0.01). Ultrastructurally, GNP and GNP-
LCD transported across BBB were observed to be distributed in a dif-
fuse pattern in the brain parenchyma of animals with or without TLE 
and had a tendency to aggregate in clumps. The results of this study 
show that GNP, a nanocarrier, may play an effective role in transferring 
effective doses of LCD into the brain in TLE therapy and hence, may 
represent a new approach in the treatment of epilepsy.
Keywords: Gold nanoparticle, Drug delivery, Blood–brain barrier, 
Lacosamide, Temporal lobe epilepsy
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The pathophysiological mechanisms underpinning the blood brain 
barrier (BBB) dysfunction in hepatic encephalopathy (HE) are complex 
and remain to be fully unraveled. While the central role of hyperam-
monemia in the BBB impairment in HE remains undisputed, differ-
ences between the effects of ammonia and toxic events related to liver 
failure, including the inflammatory responses, are currently a matter of 
intensive investigations. Recent data indicate that functioning of BBB 
is modulated by the non-coding single-stranded RNAs-microRNAs 
(miRNAs). In this study the expression of miRNAs was profiled in cer-
ebral cortices of rats subjected to simple hyperammonemia (HA) and 
hepatic failure in the thioacetamide (TAA) model using miRNA micro-
array technique. The ultimate goal was to analyze the roles of selected 
miRNAs in the development of BBB disruption by identifying their 
specific molecular targets. Altered expression of miRNAs was observed 
in the cortex of both TAA and HA rats. Target analysis revealed that 
several of the pro-inflammatory and related genes are targets of the 
downregulated miRNAs. The results suggest that the inflammation-
related aspect of BBB damage in HE may be epigenetically regulated 
by miRNA in hyperammonemic conditions related or not related to 
liver dysfunction. Detailed analysis of the differences between miRNA 
responses in HA and TAA rats is under way and will be presented.
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Blood–brain barrier (BBB) research by our group has had a positive 
impact on improving survival and long-term outcomes in patients 
with primary and metastatic brain tumors in three areas: (1) brain 
tumor therapy, (2) neuroimaging, and (3) the prevention of platinum-
induced ototoxicity.
1. BBB disruption (BBBD) chemotherapy. In a multi-institutional 
PCNSL clinical trial we showed that methotrexate-based chemo-
therapy in conjunction with BBBD results in successful and dura-
ble tumor control and outcomes that are comparable or superior 
to other PCNSL treatment regimens [1]. Prospective evaluation 
of PCNSL survivors who were treated with BBBD chemotherapy 
showed stable or improved cognitive status at a median follow-
up of 12 years after diagnosis [2]. Patients receiving BBBD chem-
otherapy in our series showed equivalent cognition and neuro-
imaging outcomes compared to patients treated with high dose 
methotrexate without BBBD [3]. Current studies are evaluating 
immunotherapy with monoclonal antibodies (mAb) targeting 
B-lymphoma antigens as a mechanism to further improve the 
complete response rate and overall survival.
2. Novel magnetic resonance imaging (MRI) techniques for meas-
uring changes in brain tumor vasculature and inflammation. In 
preclinical brain tumor studies, ferumoxytol improves the con-
sistency of relative cerebral blood volume (rCBV) measurements 
in rats before and after treatment with anti-angiogenic and thera-
peutic mAbs [4]. At later time points, >24 h, ferumoxytol crosses 
the BBB in intracerebral lesions where it is taken up by activated 
microglia, astrocytes, and tumor-associated macrophages [5]. 
Neuroimaging with ferumoxytol provides a mechanism to dif-
ferentiate tumor progression from pseudoprogression, which can 
resolve the clinical dilemma of continuation of effective therapy 
or transferring non-responders to novel therapies.
3. Chemoprotection and chemo-enhancement for brain tumor 
therapy. Platinum-based chemotherapy is used to treat a variety 
of childhood malignancies, but is associated with progressive and 
irreversible toxicities, in particular ototoxicity [6]. Research from 
our lab has shown that the thiols N-acetylcysteine (NAC) and 
sodium thiosulfate (STS) can protect against cisplatin-induced 
ototoxicity, and NAC is also protective against bone marrow and 
kidney toxicity. In patients with brain tumors treated with carbo-
platin based chemotherapy in conjunction with BBBD, we have 
shown that STS protects against carboplatin-based hearing loss 
and may also protect against carboplatin-induced severe throm-
bocytopenia [7]. To date, STS has been shown to be protective 
against cisplatin-induced hearing loss in children, and has not 
shown any evidence of tumor protection in children with local-
ized disease.
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Plasma membrane surface charge originating from negatively charged 
lipid head groups and the glycocalyx play an important role as a 
defence system at the blood–brain barrier. It can regulate permeabil-
ity across brain endothelial cells including drug transport. Lidocaine, a 
cationic and lipophilic molecule used as anaesthetic and antiarrhyth-
mic drug can change the surface charge of lipid membranes, and this 
is one of the hypothesized ways of its mode of action. However, the 
direct action of lidocaine on surface charge of endothelial cells was 
not yet measured. Our aim was to study the direct effect of lidocaine 
on the surface charge and barrier properties of brain endothelial cells.
Surface charge of hCMEC/D3 human brain endothelial cells was meas-
ured by Zetasizer Nano (Malvern). Barrier properties of hCMEC/D3 
monolayers were evaluated by measuring transendothelial electrical 
resistance, permeability for hydrophilic marker molecules, and mor-
phology of intercellular junctions stained by immunochemistry.
Lidocaine changed the surface charge of the brain endothelial cells, 
the negative zeta potential became more positive. After both short 
term (30 min) and 2-day lidocaine treatment a decrease in the elec-
trical resistance of brain endothelial monolayers was found indicat-
ing an increased ion movement across the paracellular space, but no 
significant change was detected in the permeability for large paracel-
lular marker molecules or in the morphology of interendothelial junc-
tions. We suggest that the effect of lidocaine is due to a change in the 
lipid part of the plasma membrane, which became more positive after 
lidocaine treatment. As a summary, we could demonstrate by direct 
measurements, that lidocaine makes the surface charge of human 
brain endothelial cells more positive. While lidocaine may not damage 
directly the blood–brain barrier in  vivo, a significant surface change 
in brain endothelial cells may modulate brain penetration of charged 
drug molecules.
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